<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28700680</article-id><article-id pub-id-type="pmc">5507497</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0180177</article-id><article-id pub-id-type="publisher-id">PONE-D-16-38118</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Complementary and Alternative Medicine</subject><subj-group><subject>Acupuncture</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pain Management</subject><subj-group><subject>Acupuncture</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Women's Health</subject><subj-group><subject>Obstetrics and Gynecology</subject><subj-group><subject>Menstrual Abnormalities</subject><subj-group><subject>Dysmenorrhoea</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pharmacology</subject><subj-group><subject>Drugs</subject><subj-group><subject>Analgesics</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pain Management</subject><subj-group><subject>Analgesics</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Diagnostic Medicine</subject><subj-group><subject>Signs and Symptoms</subject><subj-group><subject>Pain</subject><subj-group><subject>Abdominal Pain</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pathology and Laboratory Medicine</subject><subj-group><subject>Signs and Symptoms</subject><subj-group><subject>Pain</subject><subj-group><subject>Abdominal Pain</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Health Care</subject><subj-group><subject>Quality of Life</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Surgical and Invasive Medical Procedures</subject><subj-group><subject>Functional Electrical Stimulation</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Mental Health and Psychiatry</subject></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Sensory Physiology</subject><subj-group><subject>Somatosensory System</subject><subj-group><subject>Pain Sensation</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Sensory Physiology</subject><subj-group><subject>Somatosensory System</subject><subj-group><subject>Pain Sensation</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Neuroscience</subject><subj-group><subject>Sensory Systems</subject><subj-group><subject>Somatosensory System</subject><subj-group><subject>Pain Sensation</subject></subj-group></subj-group></subj-group></subj-group></subj-group></article-categories><title-group><article-title>The role of treatment timing and mode of stimulation in the treatment of primary dysmenorrhea with acupuncture: An exploratory randomised controlled trial</article-title><alt-title alt-title-type="running-head">An RCT on changing acupuncture dose in primary dysmenorrhea</alt-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-7539-9851</contrib-id><name><surname>Armour</surname><given-names>Mike</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="corresp" rid="cor001">*</xref></contrib><contrib contrib-type="author"><name><surname>Dahlen</surname><given-names>Hannah G.</given-names></name><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Zhu</surname><given-names>Xiaoshu</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Farquhar</surname><given-names>Cindy</given-names></name><xref ref-type="aff" rid="aff003"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Smith</surname><given-names>Caroline A.</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib></contrib-group><aff id="aff001"><label>1</label>
<addr-line>The National Institute of Complementary Medicine, Western Sydney University, Sydney, Australia</addr-line></aff><aff id="aff002"><label>2</label>
<addr-line>School of Nursing and Midwifery, Western Sydney University, Sydney, Australia</addr-line></aff><aff id="aff003"><label>3</label>
<addr-line>Department of Obstetrics and Gynaecology, University of Auckland, Auckland, New Zealand</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Scherer</surname><given-names>Roberta W.</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1"><addr-line>Johns Hopkins University Bloomberg School of Public Health, UNITED STATES</addr-line></aff><author-notes><fn fn-type="COI-statement" id="coi001"><p><bold>Competing Interests: </bold>MA is the director of an acupuncture clinic in New Zealand and has recently been engaged in integrative medicine clinical practice. MA, CS and XZ are part of NICM. As a medical research institute, NICM receives research grants and donations from foundations, universities, government agencies, individuals and industry. Sponsors and donors provide untied funding for work to advance the vision and mission of the Institute. The project that is the subject of this article was not undertaken as part of a contractual relationship with any organisation other than the funding declared in the Acknowledgments. It should also be noted that NICM conducts clinical trials relevant to this topic area, for which further details can be provided on request. This does not alter our adherence to PLOS ONE policies on sharing data and materials.</p></fn><fn fn-type="con"><p><list list-type="simple"><list-item><p><bold>Conceptualization:</bold> MA CS HD XZ CF.</p></list-item><list-item><p><bold>Data curation:</bold> MA.</p></list-item><list-item><p><bold>Formal analysis:</bold> MA CS CF.</p></list-item><list-item><p><bold>Investigation:</bold> MA.</p></list-item><list-item><p><bold>Methodology:</bold> MA CS HD XZ CF.</p></list-item><list-item><p><bold>Project administration:</bold> MA CS HD.</p></list-item><list-item><p><bold>Resources:</bold> MA CS HD XZ.</p></list-item><list-item><p><bold>Supervision:</bold> CS HD XZ CF.</p></list-item><list-item><p><bold>Visualization:</bold> MA CS CF.</p></list-item><list-item><p><bold>Writing &#x02013; original draft:</bold> MA.</p></list-item><list-item><p><bold>Writing &#x02013; review &#x00026; editing:</bold> MA CS HD XZ CF.</p></list-item></list>
</p></fn><corresp id="cor001">* E-mail: <email>m.armour@westernsydney.edu.au</email></corresp></author-notes><pub-date pub-type="epub"><day>12</day><month>7</month><year>2017</year></pub-date><pub-date pub-type="collection"><year>2017</year></pub-date><volume>12</volume><issue>7</issue><elocation-id>e0180177</elocation-id><history><date date-type="received"><day>22</day><month>9</month><year>2016</year></date><date date-type="accepted"><day>18</day><month>5</month><year>2017</year></date></history><permissions><copyright-statement>&#x000a9; 2017 Armour et al</copyright-statement><copyright-year>2017</copyright-year><copyright-holder>Armour et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="pone.0180177.pdf"/><abstract><sec id="sec001"><title>Objectives</title><p>We examined the effect of changing treatment timing and the use of manual, electro acupuncture on the symptoms of primary dysmenorrhea.</p></sec><sec id="sec002"><title>Methods</title><p>A randomised controlled trial was performed with four arms, low frequency manual acupuncture (LF-MA), high frequency manual acupuncture (HF-MA), low frequency electro acupuncture (LF-EA) and high frequency electro acupuncture (HF-EA). A manualised trial protocol was used to allow differentiation and individualized treatment over three months. A total of 74 women were randomly assigned to one of the four groups (LF-MA n = 19, HF-MA n = 18, LF-EA n = 18, HF-EA n = 19). Twelve treatments were performed over three menstrual cycles, either once per week (LF groups) or three times in the week prior to menses (HF groups). All groups received a treatment in the first 48 hours of menses. The primary outcome was the reduction in peak menstrual pain at 12 months from trial entry.</p></sec><sec id="sec003"><title>Results</title><p>During the treatment period and nine month follow-up all groups showed statistically significant (p &#x0003c; .001) reductions in peak and average menstrual pain compared to baseline but there were no differences between groups (p &#x0003e; 0.05). Health related quality of life increased significantly in six domains in groups having high frequency of treatment compared to two domains in low frequency groups. Manual acupuncture groups required less analgesic medication than electro-acupuncture groups (p = 0.02). HF-MA was most effective in reducing secondary menstrual symptoms compared to both&#x02013;EA groups (p&#x0003c;0.05).</p></sec><sec id="sec004"><title>Conclusion</title><p>Acupuncture treatment reduced menstrual pain intensity and duration after three months of treatment and this was sustained for up to one year after trial entry. The effect of changing mode of stimulation or frequency of treatment on menstrual pain was not significant. This may be due to a lack of power. The role of acupuncture stimulation on menstrual pain needs to be investigated in appropriately powered randomised controlled trials.</p></sec></abstract><funding-group><award-group id="award001"><funding-source><institution>Australian Postgraduate Award</institution></funding-source><award-id>PhD candidature funding</award-id><principal-award-recipient><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-7539-9851</contrib-id><name><surname>Armour</surname><given-names>Mike</given-names></name></principal-award-recipient></award-group><funding-statement>This study was funded in part by the Australian federal government via their Australian postgraduate award to MA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><fig-count count="2"/><table-count count="5"/><page-count count="20"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>All relevant data are within the paper and its Supporting Information files.</p></notes></front><body><sec sec-type="intro" id="sec005"><title>Introduction</title><p>Primary dysmenorrhea is defined as menstrual pain in the absence of any organic cause and is most common in women under the age of 25. Primary dysmenorrhea&#x02019;s characteristic symptom is crampy, colicky spasms of pain in the suprapubic area, occurring within 8&#x02013;72 hours of menstruation and peaking within the first few days as menstrual flow increases[<xref rid="pone.0180177.ref001" ref-type="bibr">1</xref>]. In addition to painful cramps, many women with primary dysmenorrhea experience other menstrual-related symptoms, including back and thigh pain, headaches, diarrhoea, nausea and vomiting[<xref rid="pone.0180177.ref001" ref-type="bibr">1</xref>]. Pain commonly starts within three years of menarche[<xref rid="pone.0180177.ref002" ref-type="bibr">2</xref>] and results in life time world-wide prevalence rates ranging from 17&#x02013;81%[<xref rid="pone.0180177.ref003" ref-type="bibr">3</xref>] with 71% of Australian women suffering from dysmenorrhea in a given year[<xref rid="pone.0180177.ref004" ref-type="bibr">4</xref>]. Primary dysmenorrhea is the most common cause for school absenteeism in women [<xref rid="pone.0180177.ref005" ref-type="bibr">5</xref>] and in 10&#x02013;30% of women causes regular absence from work, school or university each month [<xref rid="pone.0180177.ref006" ref-type="bibr">6</xref>, <xref rid="pone.0180177.ref007" ref-type="bibr">7</xref>]. In addition to absenteeism primary dysmenorrhea causes a reduction in academic performance [<xref rid="pone.0180177.ref008" ref-type="bibr">8</xref>, <xref rid="pone.0180177.ref009" ref-type="bibr">9</xref>], reduced participation in sport and social activities[<xref rid="pone.0180177.ref008" ref-type="bibr">8</xref>] and an overall significant decrease in women&#x02019;s quality of life [<xref rid="pone.0180177.ref009" ref-type="bibr">9</xref>, <xref rid="pone.0180177.ref010" ref-type="bibr">10</xref>]. Despite the significant negative impact and disruption to daily living that primary dysmenorrhea has on women most do not seek medical treatment [<xref rid="pone.0180177.ref011" ref-type="bibr">11</xref>, <xref rid="pone.0180177.ref012" ref-type="bibr">12</xref>].When women do present to their doctor with primary dysmenorrhea, the most commonly prescribed treatments are non-steroidal anti-inflammatories (NSAIDs) and the combined oral contraceptive (COC) pill. These treatments are effective for many women [<xref rid="pone.0180177.ref002" ref-type="bibr">2</xref>, <xref rid="pone.0180177.ref013" ref-type="bibr">13</xref>], however approximately 25% of women have pain that is refractory to either or both of these standard treatments[<xref rid="pone.0180177.ref014" ref-type="bibr">14</xref>].</p><p>Lack of satisfaction in standard treatment leads to an increase in self-care [<xref rid="pone.0180177.ref015" ref-type="bibr">15</xref>, <xref rid="pone.0180177.ref016" ref-type="bibr">16</xref>], with women commonly using complementary therapies to deal with their menstrual pain[<xref rid="pone.0180177.ref017" ref-type="bibr">17</xref>] in addition to, or instead of, pharmaceutical pain relief, due to a lack of perceived effectiveness[<xref rid="pone.0180177.ref015" ref-type="bibr">15</xref>, <xref rid="pone.0180177.ref018" ref-type="bibr">18</xref>, <xref rid="pone.0180177.ref019" ref-type="bibr">19</xref>] or a dislike of using analgesic medication[<xref rid="pone.0180177.ref020" ref-type="bibr">20</xref>]. Surveys of practice show women are presenting to acupuncturists in the community with gynaecological complaints such as primary dysmenorrhea [<xref rid="pone.0180177.ref021" ref-type="bibr">21</xref>] despite the evidence for acupuncture&#x02019;s effectiveness in treating primary dysmenorrhea being uncertain[<xref rid="pone.0180177.ref022" ref-type="bibr">22</xref>]. Many clinical trials are characterised as having a high risk of bias or a lack of clinical validity due to a significant departure from how acupuncture is delivered in contemporary clinical practice.</p><p>Despite the lack of high quality evidence there are plausible mechanisms of action for acupuncture to improve primary dysmenorrhea, including endogenous opioid release[<xref rid="pone.0180177.ref023" ref-type="bibr">23</xref>], reduction of inflammation [<xref rid="pone.0180177.ref024" ref-type="bibr">24</xref>], alterations in uterine blood flow[<xref rid="pone.0180177.ref025" ref-type="bibr">25</xref>] and changes in prostaglandin levels [<xref rid="pone.0180177.ref026" ref-type="bibr">26</xref>]. Acupuncture appears to show a dose response relationship between various needling parameters and pain [<xref rid="pone.0180177.ref027" ref-type="bibr">27</xref>]. There is some evidence that electro-acupuncture provides a more rapid reduction in menstrual pain compared to manual acupuncture; however this finding was based on a single study that used an uncommon style of indwelling acupuncture administered only during menses and assessed using non-validated outcome measures [<xref rid="pone.0180177.ref028" ref-type="bibr">28</xref>]. The timing of treatment around menses has been examined in two studies [<xref rid="pone.0180177.ref029" ref-type="bibr">29</xref>, <xref rid="pone.0180177.ref030" ref-type="bibr">30</xref>] which suggested that treatment three to seven days prior to menses was more effective than treatment during menses. No previous trials have directly investigated the possible dose response relationship that appears to be present between the use of electro-acupuncture and manual acupuncture or in changing frequency of treatment in a western clinical setting where use of manual acupuncture delivered once per week is more common.</p><p>This exploratory study aims to examine the possible impact of changing the mode of acupuncture stimulation and treatment timing on menstrual pain. We hypothesised that both electro-acupuncture and higher frequency of treatment would deliver greater reductions in menstrual pain and greater improvements in health-related quality of life compared to lower frequency or manual acupuncture.</p></sec><sec sec-type="materials|methods" id="sec006"><title>Materials and methods</title><sec id="sec007"><title>Study design</title><p>An exploratory study using a 2x2 factorial design, to test the individual and combined effects of changing 1) treatment timing, and 2) mode of stimulation. This study used a pragmatic clinical trial design with some qualifications, including the use of a manualised acupuncture protocol designed to reduce the amount of variation between practitioners (<xref ref-type="supplementary-material" rid="pone.0180177.s002">S1 File</xref>). This design allows for a balance between removing excessive inter-practitioner variation and still encompassing the complex nature of traditional Chinese medicine (TCM) clinical practice [<xref rid="pone.0180177.ref031" ref-type="bibr">31</xref>]. When evaluating a complex intervention or &#x0201c;package of care,&#x0201d; such as TCM acupuncture, a design slanted towards the pragmatic effectiveness end of the continuum is more appropriate and increases the ecological validity of the outcome [<xref rid="pone.0180177.ref032" ref-type="bibr">32</xref>]. Acupuncture-specific reporting in this trial follows the revised Standards for Reporting Interventions in Clinical Trials of Acupuncture [<xref rid="pone.0180177.ref033" ref-type="bibr">33</xref>].</p><p>The University of Western Sydney Human Ethics Committee (H10082) and the Health and Disability Ethics Committee New Zealand (13/CEN/60) approved this study. Maori approval was obtained from the Office of Tumuaki along with locality assessments for the clinic sites in Auckland and Wellington through the Health and Disability Ethics Committee New Zealand. Written consent was obtained from all participants before trial entry. The trial was prospectively registered with the Australian New Zealand Clinical Trials Registry (<ext-link ext-link-type="uri" xlink:href="https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=363933">https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=363933</ext-link>) ACTRN12613000351718. Recruitment ran from June 2013 to January 2014.</p></sec><sec id="sec008"><title>Participants</title><p>Eligible participants were aged 18&#x02013;45 years, with suspected or confirmed primary dysmenorrhea as defined by the following: a history of period pain beginning before the age of 18, or period pain beginning after the age of 18, but gynaecological investigations by laparoscopy or ultrasound scan showing no evidence of secondary dysmenorrhea, pain greater than or equal to 3 out of 10 on a numeric rating scale during the first three days of menses for at least two of the past three menstrual cycles, regular menstrual cycles (28 +/- 5 days) for the last three months, spoken and written English skills and able to give informed consent.</p><p>Exclusion criteria included a previous diagnosis of endometriosis or secondary dysmenorrhea, abdominal surgery in the previous three months, injectable or implant contraceptives (Depo Provera, Jadelle, Mirena) within the last three months, oral contraceptive usage started less than three months prior to enrolment, chronic pain conditions (&#x0003e;14 days per month with pain), current untreated mental health illness, neuropathic pain secondary to surgery, sterilisation.</p></sec><sec id="sec009"><title>Recruitment</title><p>Based on prevalence data we expected the majority of potential participants to be aged under 25 [<xref rid="pone.0180177.ref006" ref-type="bibr">6</xref>]. Most of these women would not have discussed their condition with their general practitioner [<xref rid="pone.0180177.ref010" ref-type="bibr">10</xref>, <xref rid="pone.0180177.ref034" ref-type="bibr">34</xref>] therefore we used similar promotion and recruitment strategies to Griffin [<xref rid="pone.0180177.ref035" ref-type="bibr">35</xref>] with promotion of the study focussed on distributing study information using university email lists, flyers and posters placed on campus. In addition, a Facebook advertisement and Google Ad-words were created in conjunction with the University of Western Sydney (UWS) social media committee. Both of these linked the participant with the UWS study website which provided more information and the contact details of the researcher. Facebook advertisements were targeted to women, aged 18&#x02013;45 years living within 60 miles of Auckland and Wellington, New Zealand. Sixty miles was chosen as a suitable radius as it was considered unlikely that women outside this distance would be happy to travel in for treatment if randomised to either of the high-frequency groups. Upon contacting the primary investigator, women were assessed for initial eligibility. Women were then instructed to fill in a menstrual pain diary during their next menstrual period and this was assessed to confirm the presence of cycle length, pain levels and pain characteristics indicative of primary dysmenorrhea. Menstrual pain diary and baseline data were assessed to confirm eligibility before randomisation occurred. <xref ref-type="fig" rid="pone.0180177.g001">Fig 1</xref> outlines the participant flow in the trial.</p><fig id="pone.0180177.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0180177.g001</object-id><label>Fig 1</label><caption><title>CONSORT flow diagram.</title></caption><graphic xlink:href="pone.0180177.g001"/></fig><p>Randomisation was computer generated and allocation was concealed by way of an internet-based randomisation service, Sealed Envelope (<ext-link ext-link-type="uri" xlink:href="https://www.sealedenvelope.com/">www.sealedenvelope.com</ext-link>). Randomisation into one of four study groups using a 1:1:1:1 ratio was undertaken using the web interface by the primary investigator (MA). The four groups were, high frequency, manual acupuncture (HF&#x02013;MA), high frequency, electro acupuncture (HF&#x02013;EA), low frequency, manual acupuncture (LF&#x02013;MA), low frequency, electro acupuncture (LF&#x02013;EA).</p></sec><sec id="sec010"><title>Treatment protocol</title><p>All women in the study were scheduled to receive 12 treatments over the course of three menstrual cycles. Women in the high frequency (HF) group received three treatments in the seven days prior to the estimated day one of the menstrual cycle. Women in the low frequency (LF) group received three treatments in the time between menses, approximately every seven to ten days&#x02019; dependent on cycle length. All groups received a treatment in the first two days of menses (day one or day two of the menses). In the manual acupuncture groups (-MA) all needles were stimulated by hand using tonifying, reducing or even method, based on the practitioner&#x02019;s clinical judgement approximately 10&#x02013;15 minutes after needle insertion was completed. In the electro-acupuncture groups (-EA) Two distal points (from the previously chosen point prescription) were selected by the practitioner and a 2Hz / 100Hz square wave pulse of 200ms duration was applied between each point for 20 minutes using an ITO ES-160 electro-acupuncture machine (Ito Co. Ltd, Japan). Intensity level was based on patient feedback; noticeable sensation present, but below the threshold for discomfort. All initial consultations were allocated 60 minutes, with follow-up consultations of 45 minutes&#x02019; duration.</p><p>The manualised protocol was based on data collected from an international survey of experienced women&#x02019;s health practitioners [<xref rid="pone.0180177.ref021" ref-type="bibr">21</xref>] and focus groups [<xref rid="pone.0180177.ref012" ref-type="bibr">12</xref>]. Treatment was based on TCM&#x02019;s eight principles and Zang Fu diagnosis. Once a TCM diagnosis had been ascertained, the practitioners had the flexibility with their point selection to address the diagnosed pattern of disharmony as per the treatment handbook. Each subsequent treatment session would allow for a confirmation or update on the TCM diagnosis and therefore point selection could vary from treatment to treatment. Multiple patterns of disharmony are common in dysmenorrhea[<xref rid="pone.0180177.ref036" ref-type="bibr">36</xref>] and this trial supported up to two concurrent patterns of disharmony, designated as root (primary) and secondary (branch) patterns. In all cases no more than seven acupuncture points were to be used. <xref ref-type="supplementary-material" rid="pone.0180177.s001">S1 Fig</xref> outlines how point selection occurred in both patients with one or two TCM patterns. Acupuncture points were needled bilaterally, except those where only one side was used clinically, such as opening extraordinary vessels such as the Chong Mai. Point location and needling depth was as specified in A Manual of Acupuncture [<xref rid="pone.0180177.ref037" ref-type="bibr">37</xref>]. Single use, stainless steel needles of varying gauge (.20 x 30mm or .25 x 40mm, DongBang, Korea) were used. <italic>DeQi</italic> (the arrival of Qi) is the sensation generated by the insertion and/or manipulation of an acupuncture needle in an acupuncture point [<xref rid="pone.0180177.ref038" ref-type="bibr">38</xref>]. In all groups DeQi was obtained for each acupuncture point at the beginning of the session and needles were retained for 20&#x02013;30 minutes. Each pattern also has moxibustion as a compulsory, optional or forbidden component of the treatment. Indirect moxa was administered via smokeless moxa stick for 5&#x02013;10 minutes on one of the selected acupuncture points. Each patient was given a diet and lifestyle advice sheet during their first treatment session. These were grounded in TCM theory.</p></sec><sec id="sec011"><title>Blinding</title><p>Participants were not blinded to group allocation. Data entry was undertaken blind to the study group, and analysis was undertaken blind to group allocation.</p></sec><sec id="sec012"><title>Outcomes</title><p>Changes in menstrual pain and other secondary symptoms were measured using a menstrual pain diary (MPD) that was designed by the authors (See <xref ref-type="supplementary-material" rid="pone.0180177.s003">S2 File</xref>). This was used to assess the changes in pain, analgesic intake, menstrual characteristics and secondary symptoms, and allowed women to self-rate the severity of their dysmenorrhea in both intensity and duration of pain, as well as the presence of secondary symptoms. The primary data endpoint used an 11-point numerical rating scale (NRS) for both &#x0201c;peak&#x0201d; and &#x0201c;average&#x0201d; pain each day, with 0 being no pain and 10 being the worst pain imaginable. The NRS has a high compliance rate, is easy to use, preferred by chronic pain patients and fits the compact format of a menstrual diary [<xref rid="pone.0180177.ref039" ref-type="bibr">39</xref>]. The diary also collected information on duration of menstrual pain each day (hours or &#x0201c;all day&#x0201d;), secondary menstrual symptoms, including breast tenderness, emotional changes, nausea etc. and analgesic usage (brand / pharmaceutical name, dosage and number of doses per day) This MPD could be filled in either in hard copy or using a webform. Both were identical in content and layout. The diary was completed by the participant at the conclusion of the day during either the menstrual period itself or one to two days prior to the menstrual period if they were experiencing sharp, stabbing, cramping or aching pain in the lower abdomen or lower back that they would normally associate with their period. The MPD was administered at baseline, at each of the three menstrual periods during the study, the menstrual period following the completion of the study, and at one, six and 12 months after the conclusion of the study.</p><p>Health related quality of life (HRQoL) was measured using the <bold>36</bold>-Item Short Form Health Survey (SF-36v2). The SF-36 has been shown to be valid and reliable [<xref rid="pone.0180177.ref040" ref-type="bibr">40</xref>], and has previously shown suitability for use in dysmenorrhea[<xref rid="pone.0180177.ref041" ref-type="bibr">41</xref>]. The SF-36v2 was self-administered at baseline (prior to the first acupuncture session) and again at one-month follow-up (post-trial completion).</p><p>An exit questionnaire was also used to determine self-reported improvement score, treatment satisfaction and to record which, if any, symptoms of primary dysmenorrhea improved (See <xref ref-type="supplementary-material" rid="pone.0180177.s004">S3 File</xref>).</p><p>The decision to calculate a responder rate was made <italic>a posteriori</italic>. The responder rate provides clinically meaningful information on the magnitude of pain reduction, in addition to the continuous outcome data. Responder rates were calculated for the primary outcome measures between baseline and one-month follow up, due to the significant loss to follow-up at 6 and 12 months. A recent review of chronic pain has shown that the threshold of a 30% reduction in pain scores is where patients feel a clinically important change has occurred [<xref rid="pone.0180177.ref042" ref-type="bibr">42</xref>]. However, the choice of responder rate can appear arbitrary and possibly bias the results, therefore providing a range of responder rates allows a more transparent view of the data [<xref rid="pone.0180177.ref043" ref-type="bibr">43</xref>]. Numeric data for responder rates is provided for 30%, 50% and 70% reductions from baseline.</p></sec><sec id="sec013"><title>Sample size</title><p>This trial was designed explore a difference in peak pain intensity on the first 3 days of the menstrual period between groups as measured by the Numeric Rating Scale (NRS). A minimal clinically important 20% difference between groups was expected and based on previous study data [<xref rid="pone.0180177.ref044" ref-type="bibr">44</xref>], a standard deviation of 1.3 units on a pain scale was used. An alpha of 0.05 and power of 90% gives a total sample size of 60 women. A power calculation was performed using G*Power 3(G*Power: Statistical Power Analyses for Windows and Mac, Universit&#x000e4;t D&#x000fc;sseldorf). Previous studies [<xref rid="pone.0180177.ref044" ref-type="bibr">44</xref>, <xref rid="pone.0180177.ref045" ref-type="bibr">45</xref>] had relatively low loss to follow-up (&#x0003c;15%), therefore a sample size of 72 women (18 per group) was used to account for the predicted loss to follow-up of 10&#x02013;15%.</p></sec><sec id="sec014"><title>Analysis</title><p>Data analysis used descriptive statistics and inferential statistics to examine the demographic and baseline characteristics. All statistical calculations were performed using IBM SPSS Statistics v23 (IBM Corporation). Age, BMI, age of menarche, analgesic usage, expectation, smoking and alcohol status, peak pain on the first three days of the menstrual period, average pain and SF-36 scores were compared between groups at baseline using one-way ANOVA for continuous data or chi-square for categorical data to ensure randomisation was successful. Differences at baseline are reported as means and standard deviations or frequencies and percentages. Both an &#x02018;intention to treat&#x02019; approach and a per protocol analysis were undertaken for the primary and secondary endpoints. The menstrual symptoms score was calculated as the mean number of symptoms per participant per day. Average pain for each menstrual cycle was calculated as the mean of each days &#x02018;average pain&#x02019; score over each menstrual period. Pre-planned contrasts were to compare mode of stimulation (MA vs EA) and frequency of treatment (HF vs LF) and the effect of these combinations via the four different groups. Differences in the primary and secondary outcome measures were analysed using linear mixed model analysis of variance with either i) group and time as fixed effects or ii) mode of stimulation, frequency of treatment and time as fixed effects. In all linear mixed models subject was a used as a random effect. Any interactions between group and time, mode of stimulation and time and frequency of treatment and time were investigated. Due to the small sample size all p-values are exploratory. All pre-planned <italic>post hoc</italic> tests used Sidak for multiple pairwise comparisons. In the secondary analysis where means have been adjusted by SF-36 Role Physical, expectation of benefit and current alcohol consumption, all relevant tables report both adjusted and unadjusted means.</p></sec></sec><sec sec-type="results" id="sec015"><title>Results</title><p>A total of 106 women expressed interest in the study (See <xref ref-type="fig" rid="pone.0180177.g001">Fig 1</xref>). Seventy-four women met the eligibility criteria and were randomised to one of the four groups. Sixty-three (85%) women completed the treatment phase of the trial. Ten participants withdrew during the treatment phase of the trial. Withdrawal from the trial was equally distributed across groups, with none of the women citing any group-related concerns as reason for withdrawal.</p><p>The demographic and menstrual characteristics of the women at baseline are shown in <xref ref-type="table" rid="pone.0180177.t001">Table 1</xref>. One-way ANOVA and Pearson Chi-square showed three areas of imbalance between the groups at baseline, in SF-36 role physical (F(3,69) = 1.12, p = 0.008), in expectation of benefit (&#x003c7;(6) = 13.205, p = 0.04) and in current alcohol consumption (&#x003c7;(3) = 8.562, p = 0.036). These were used as co-variates in the secondary analysis.</p><table-wrap id="pone.0180177.t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0180177.t001</object-id><label>Table 1</label><caption><title>Baseline demographic and health characteristics of women at trial entry.</title></caption><alternatives><graphic id="pone.0180177.t001g" xlink:href="pone.0180177.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">HF-MA (n = 18)</th><th align="left" rowspan="1" colspan="1">HF-EA (n = 19)</th><th align="left" rowspan="1" colspan="1">LF-MA (n = 19)</th><th align="left" rowspan="1" colspan="1">LF-EA (n = 18)</th><th align="left" rowspan="1" colspan="1">Total (N = 74)</th><th align="left" rowspan="1" colspan="1">p-value</th></tr><tr><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">mean (SD)</th><th align="left" rowspan="1" colspan="1">mean (SD)</th><th align="left" rowspan="1" colspan="1">mean (SD)</th><th align="left" rowspan="1" colspan="1">mean (SD)</th><th align="left" rowspan="1" colspan="1">mean (SD)</th><th align="left" rowspan="1" colspan="1"/></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><italic>Demographic</italic></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Age</bold></td><td align="left" rowspan="1" colspan="1">29.9 (7.2)</td><td align="left" rowspan="1" colspan="1">31.2 (7.4)</td><td align="left" rowspan="1" colspan="1">31.1 (6.6)</td><td align="left" rowspan="1" colspan="1">29.3 (5.6)</td><td align="left" rowspan="1" colspan="1">30.4 (6.7)</td><td align="left" rowspan="1" colspan="1">0.80</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>BMI (n %)<xref ref-type="table-fn" rid="t001fn002">*</xref></bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="right" rowspan="1" colspan="1">Underweight</td><td align="left" rowspan="1" colspan="1">0 (0.0)</td><td align="left" rowspan="1" colspan="1">2 (10.5)</td><td align="left" rowspan="1" colspan="1">1 (5.2)</td><td align="left" rowspan="1" colspan="1">0 (0.0)</td><td align="left" rowspan="1" colspan="1">3 (4.0)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="right" rowspan="1" colspan="1">Normal</td><td align="left" rowspan="1" colspan="1">9 (50.0)</td><td align="left" rowspan="1" colspan="1">8 (42.1)</td><td align="left" rowspan="1" colspan="1">13 (68.4)</td><td align="left" rowspan="1" colspan="1">11 (61.1)</td><td align="left" rowspan="1" colspan="1">41 (55.4)</td><td align="left" rowspan="1" colspan="1">0.50</td></tr><tr><td align="right" rowspan="1" colspan="1">Overweight</td><td align="left" rowspan="1" colspan="1">4 (22.2)</td><td align="left" rowspan="1" colspan="1">6 (31.5)</td><td align="left" rowspan="1" colspan="1">4 (21.0)</td><td align="left" rowspan="1" colspan="1">4 (22.2)</td><td align="left" rowspan="1" colspan="1">18 (24.3)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="right" rowspan="1" colspan="1">Obese</td><td align="left" rowspan="1" colspan="1">5 (27.7)</td><td align="left" rowspan="1" colspan="1">3 (15.7)</td><td align="left" rowspan="1" colspan="1">1 (5.2)</td><td align="left" rowspan="1" colspan="1">3 (16.6)</td><td align="left" rowspan="1" colspan="1">12 (16.2)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Previously given birth</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="right" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">14 (77.7)</td><td align="left" rowspan="1" colspan="1">16 (84.2)</td><td align="left" rowspan="1" colspan="1">13 (68.4)</td><td align="left" rowspan="1" colspan="1">15 (83.3)</td><td align="left" rowspan="1" colspan="1">58 (78.4)</td><td align="left" rowspan="1" colspan="1">0.62</td></tr><tr><td align="right" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">4 (22.2)</td><td align="left" rowspan="1" colspan="1">3 (15.7)</td><td align="left" rowspan="1" colspan="1">6 (31.6)</td><td align="left" rowspan="1" colspan="1">3 (16.6)</td><td align="left" rowspan="1" colspan="1">16 (21.6)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Menstrual characteristics</italic></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Age of Menarche (years)</bold></td><td align="left" rowspan="1" colspan="1">12.5 (1.7)</td><td align="left" rowspan="1" colspan="1">12.7 (1.4)</td><td align="left" rowspan="1" colspan="1">13.2 (1.6)</td><td align="left" rowspan="1" colspan="1">12.3 (0.9)</td><td align="left" rowspan="1" colspan="1">12.7 (1.5)</td><td align="left" rowspan="1" colspan="1">0.31</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Age of onset of dysmenorrhea (years)</bold></td><td align="left" rowspan="1" colspan="1">15.8 (6.8)</td><td align="left" rowspan="1" colspan="1">13.7 (1.5)</td><td align="left" rowspan="1" colspan="1">15.9 (5.8)</td><td align="left" rowspan="1" colspan="1">13.3 (1.5)</td><td align="left" rowspan="1" colspan="1">14.7 (4.7)</td><td align="left" rowspan="1" colspan="1">0.19</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Length of menstrual cycle (days)</bold></td><td align="left" rowspan="1" colspan="1">28.1 (1.8)</td><td align="left" rowspan="1" colspan="1">28.7 (2.1)</td><td align="left" rowspan="1" colspan="1">27.8 (2.0)</td><td align="left" rowspan="1" colspan="1">28.6 (2.1)</td><td align="left" rowspan="1" colspan="1">28.3 (2.0)</td><td align="left" rowspan="1" colspan="1">0.50</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Length of menses (days)</bold></td><td align="left" rowspan="1" colspan="1">5.3 (1.9)</td><td align="left" rowspan="1" colspan="1">4.9 (0.8)</td><td align="left" rowspan="1" colspan="1">5.4 (1.2)</td><td align="left" rowspan="1" colspan="1">5.6 (1.7)</td><td align="left" rowspan="1" colspan="1">5.3 (1.2)</td><td align="left" rowspan="1" colspan="1">0.49</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Additional Menstrual Symptoms</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="right" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">0 (0)</td><td align="left" rowspan="1" colspan="1">0 (0)</td><td align="left" rowspan="1" colspan="1">0 (0)</td><td align="left" rowspan="1" colspan="1">0 (0)</td><td align="left" rowspan="1" colspan="1">0 (0)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="right" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">18 (100)</td><td align="left" rowspan="1" colspan="1">19 (100)</td><td align="left" rowspan="1" colspan="1">19 (100)</td><td align="left" rowspan="1" colspan="1">18 (100)</td><td align="left" rowspan="1" colspan="1">74 (100)</td><td align="left" rowspan="1" colspan="1">1.0</td></tr><tr><td align="right" rowspan="1" colspan="1"><bold>Pain relief with analgesia</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="right" rowspan="1" colspan="1">No&#x02014;Pain still present</td><td align="left" rowspan="1" colspan="1">2 (11.1)</td><td align="left" rowspan="1" colspan="1">2 (10.5)</td><td align="left" rowspan="1" colspan="1">0 (0.0)</td><td align="left" rowspan="1" colspan="1">0 (0.0)</td><td align="left" rowspan="1" colspan="1">4 (5.4)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="right" rowspan="1" colspan="1">Yes&#x02014;Partial Relief</td><td align="left" rowspan="1" colspan="1">13 (72.2)</td><td align="left" rowspan="1" colspan="1">16 (84.2)</td><td align="left" rowspan="1" colspan="1">15 (78.9)</td><td align="left" rowspan="1" colspan="1">17 (94.4)</td><td align="left" rowspan="1" colspan="1">61 (82.4)</td><td align="left" rowspan="1" colspan="1">0.37</td></tr><tr><td align="right" rowspan="1" colspan="1">Yes&#x02014;Complete relief</td><td align="left" rowspan="1" colspan="1">3 (16.6)</td><td align="left" rowspan="1" colspan="1">1 (5.2)</td><td align="left" rowspan="1" colspan="1">3 (15.7)</td><td align="left" rowspan="1" colspan="1">1 (5.6)</td><td align="left" rowspan="1" colspan="1">8 (10.8)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="right" rowspan="1" colspan="1"><bold>Currently drinking alcohol</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="right" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">2 (11.1)</td><td align="left" rowspan="1" colspan="1">3(15.7)</td><td align="left" rowspan="1" colspan="1">9(47.3)</td><td align="left" rowspan="1" colspan="1">3(16.6)</td><td align="left" rowspan="1" colspan="1">17 (22.9)</td><td align="left" rowspan="1" colspan="1">0.03*</td></tr><tr><td align="right" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">16 (88.9)</td><td align="left" rowspan="1" colspan="1">16(84.2)</td><td align="left" rowspan="1" colspan="1">10 (52.6)</td><td align="left" rowspan="1" colspan="1">15(83.3)</td><td align="left" rowspan="1" colspan="1">57 (77.0)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="right" rowspan="1" colspan="1"><bold>Expectation of benefit from acupuncture</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="right" rowspan="1" colspan="1">Unsure</td><td align="left" rowspan="1" colspan="1">9 (50.0)</td><td align="left" rowspan="1" colspan="1">4 (21.0)</td><td align="left" rowspan="1" colspan="1">10 (52.6)&#x000a0;</td><td align="left" rowspan="1" colspan="1">7 (38.8)</td><td align="left" rowspan="1" colspan="1">30 (40.5)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="right" rowspan="1" colspan="1">Probably will help</td><td align="left" rowspan="1" colspan="1">4 (22.2)</td><td align="left" rowspan="1" colspan="1">14 (73.6)</td><td align="left" rowspan="1" colspan="1">8 (42.1)</td><td align="left" rowspan="1" colspan="1">8 (44.4)</td><td align="left" rowspan="1" colspan="1">34 (46.0)</td><td align="left" rowspan="1" colspan="1">0.040*</td></tr><tr><td align="right" rowspan="1" colspan="1">Definitely will help</td><td align="left" rowspan="1" colspan="1">5 (27.8)</td><td align="left" rowspan="1" colspan="1">1 (5.2)</td><td align="left" rowspan="1" colspan="1">1 (5.2)</td><td align="left" rowspan="1" colspan="1">3 (16.6)</td><td align="left" rowspan="1" colspan="1">10 (13.5)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="right" rowspan="1" colspan="1"><bold>SF-36 HRQoL</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="right" rowspan="1" colspan="1">Physical function</td><td align="left" rowspan="1" colspan="1">55.8 (2.9)</td><td align="left" rowspan="1" colspan="1">55.0 (3.9)</td><td align="left" rowspan="1" colspan="1">52.8 (8.4)</td><td align="left" rowspan="1" colspan="1">53.7 (7.4)</td><td align="left" rowspan="1" colspan="1">54.3 (6.1)</td><td align="left" rowspan="1" colspan="1">0.46</td></tr><tr><td align="right" rowspan="1" colspan="1">Role physical</td><td align="left" rowspan="1" colspan="1">54.8 (5.0)</td><td align="left" rowspan="1" colspan="1">46.4 (9.7)</td><td align="left" rowspan="1" colspan="1">50.2 (7.8)</td><td align="left" rowspan="1" colspan="1">47.6 (8.0)</td><td align="left" rowspan="1" colspan="1">49.7 (8.4)</td><td align="left" rowspan="1" colspan="1">0.01 *</td></tr><tr><td align="right" rowspan="1" colspan="1">Bodily pain</td><td align="left" rowspan="1" colspan="1">49.1 (7.4)</td><td align="left" rowspan="1" colspan="1">43.6 (5.3)</td><td align="left" rowspan="1" colspan="1">44.8 (9.3)</td><td align="left" rowspan="1" colspan="1">43.4 (7.4)</td><td align="left" rowspan="1" colspan="1">44.9 (7.7)</td><td align="left" rowspan="1" colspan="1">0.08</td></tr><tr><td align="right" rowspan="1" colspan="1">General health</td><td align="left" rowspan="1" colspan="1">51.3 (10.6)</td><td align="left" rowspan="1" colspan="1">50.4 (10.4)</td><td align="left" rowspan="1" colspan="1">52.8 (9.9)</td><td align="left" rowspan="1" colspan="1">51.6 (7.7)</td><td align="left" rowspan="1" colspan="1">51.5 (9.6)</td><td align="left" rowspan="1" colspan="1">0.90</td></tr><tr><td align="right" rowspan="1" colspan="1">Vitality</td><td align="left" rowspan="1" colspan="1">48.1 (9.8)</td><td align="left" rowspan="1" colspan="1">45.4 (7.8)</td><td align="left" rowspan="1" colspan="1">48.2 (9.9)</td><td align="left" rowspan="1" colspan="1">48.9 (6.5)</td><td align="left" rowspan="1" colspan="1">47.7 (8.6)</td><td align="left" rowspan="1" colspan="1">0.61</td></tr><tr><td align="right" rowspan="1" colspan="1">Social function</td><td align="left" rowspan="1" colspan="1">50.7 (8.2)</td><td align="left" rowspan="1" colspan="1">43.9 (11.3)</td><td align="left" rowspan="1" colspan="1">44.9 (10.7)</td><td align="left" rowspan="1" colspan="1">47.6 (7.0)</td><td align="left" rowspan="1" colspan="1">46.7 (9.7)</td><td align="left" rowspan="1" colspan="1">0.15</td></tr><tr><td align="right" rowspan="1" colspan="1">Role emotional</td><td align="left" rowspan="1" colspan="1">49.6 (6.6)</td><td align="left" rowspan="1" colspan="1">47.6 (8.9)</td><td align="left" rowspan="1" colspan="1">47.6 (8.9)</td><td align="left" rowspan="1" colspan="1">49.0 (8.0)</td><td align="left" rowspan="1" colspan="1">48.4 (8.1)</td><td align="left" rowspan="1" colspan="1">0.83</td></tr><tr><td align="right" rowspan="1" colspan="1">Mental health</td><td align="left" rowspan="1" colspan="1">51.0 (6.3)</td><td align="left" rowspan="1" colspan="1">50.3 (5.8)</td><td align="left" rowspan="1" colspan="1">47.3 (8.1)</td><td align="left" rowspan="1" colspan="1">49.6 (7.2)</td><td align="left" rowspan="1" colspan="1">49.5 (6.9)</td><td align="left" rowspan="1" colspan="1">0.38</td></tr><tr><td align="right" rowspan="1" colspan="1">Overall mental component</td><td align="left" rowspan="1" colspan="1">48.1 (8.1)</td><td align="left" rowspan="1" colspan="1">44.8 (10.0)</td><td align="left" rowspan="1" colspan="1">46.1 (9.4)</td><td align="left" rowspan="1" colspan="1">47.9 (8.7)</td><td align="left" rowspan="1" colspan="1">46.7 (9.0)</td><td align="left" rowspan="1" colspan="1">0.68</td></tr><tr><td align="right" rowspan="1" colspan="1">Overall physical component</td><td align="left" rowspan="1" colspan="1">54.1 (6.6)</td><td align="left" rowspan="1" colspan="1">49.4 (6.7)</td><td align="left" rowspan="1" colspan="1">51.4 (6.3)</td><td align="left" rowspan="1" colspan="1">49.3 (6.9)</td><td align="left" rowspan="1" colspan="1">51.0 (6.8)</td><td align="left" rowspan="1" colspan="1">0.13</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t001fn001"><p>Continuous data presented as mean (SD). Categorical data as N (%).</p></fn><fn id="t001fn002"><p>* between group comparison significant (P&#x0003c;0.05)</p></fn></table-wrap-foot></table-wrap><p>However, not all women received all 12 treatments, mostly due to logistical issues around timing of treatments with regards to the start of menses. Twenty-five participants (35.2%) received the full 12 study treatments. The mean number of treatments was 10.6 [95% CI 10.22 to 10.99] for all women who had at least one study treatment. There was no difference in the number of treatments given between groups (F(3,59) = 1.855, p = 0.147).</p><p><xref ref-type="table" rid="pone.0180177.t002">Table 2</xref> outlines peak pain, average pain, duration of pain and analgesic usage for each of the groups at each time point for adjusted and unadjusted ITT analysis. See <xref ref-type="supplementary-material" rid="pone.0180177.s005">S4 File</xref> for results of the per-protocol analysis.</p><table-wrap id="pone.0180177.t002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0180177.t002</object-id><label>Table 2</label><caption><title>Changes in menstrual pain and analgesic usage between baseline and follow up.</title></caption><alternatives><graphic id="pone.0180177.t002g" xlink:href="pone.0180177.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Group</th><th align="left" colspan="2" rowspan="1">HF&#x02013;MA<break/>n = 18</th><th align="left" colspan="2" rowspan="1">HF&#x02013;EA<break/>n = 19</th><th align="left" colspan="2" rowspan="1">LF&#x02013;MA<break/>n = 19</th><th align="left" colspan="2" rowspan="1">LF&#x02013;EA<break/>n = 18</th></tr><tr><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">Unadjusted Mean [95% CI]</th><th align="left" rowspan="1" colspan="1">Adjusted Mean [95% CI]</th><th align="left" rowspan="1" colspan="1">Unadjusted Mean [95% CI]</th><th align="left" rowspan="1" colspan="1">Adjusted Mean [95% CI]</th><th align="left" rowspan="1" colspan="1">Unadjusted Mean [95% CI]</th><th align="left" rowspan="1" colspan="1">Adjusted Mean [95% CI</th><th align="left" rowspan="1" colspan="1">Unadjusted Mean [95% CI]</th><th align="left" rowspan="1" colspan="1">Adjusted Mean [95% CI]</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><bold>Peak pain (Day 1&#x02013;3 of menstrual period)</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="right" rowspan="1" colspan="1">Baseline</td><td align="center" rowspan="1" colspan="1">4.5 [3.5 to 5.4]</td><td align="center" rowspan="1" colspan="1">4.4 [3.4 to 5.5]</td><td align="center" rowspan="1" colspan="1">5.1 [4.2 to 6.0]</td><td align="center" rowspan="1" colspan="1">5.7 [4.7 to 6.8]</td><td align="center" rowspan="1" colspan="1">5.3 [4.4 to 6.2]</td><td align="center" rowspan="1" colspan="1">5.5 [4.5 to 6.5]</td><td align="center" rowspan="1" colspan="1">4.7 [3.7 to 5.7]</td><td align="center" rowspan="1" colspan="1">5.0 [3.9 to 6.0]</td></tr><tr><td align="right" rowspan="1" colspan="1">Month 1</td><td align="center" rowspan="1" colspan="1">3.4 [2.5 to 4.4]</td><td align="center" rowspan="1" colspan="1">3.4 [2.4 to 4.4]</td><td align="center" rowspan="1" colspan="1">4.0 [3.1 to 5.0]</td><td align="center" rowspan="1" colspan="1">4.6 [3.6 to 5.7]</td><td align="center" rowspan="1" colspan="1">4.7 [3.8 to 5.7]</td><td align="center" rowspan="1" colspan="1">4.9 [4.0 to 5.9]</td><td align="center" rowspan="1" colspan="1">3.8 [2.8 to 4.8]</td><td align="center" rowspan="1" colspan="1">4.0 [3.0 to 5.0]</td></tr><tr><td align="right" rowspan="1" colspan="1">Month 2</td><td align="center" rowspan="1" colspan="1">3.7 [2.8 to 4.6]</td><td align="center" rowspan="1" colspan="1">3.7 [2.6 to 4.7]</td><td align="center" rowspan="1" colspan="1">4.0 [3.0 to 4.9]</td><td align="center" rowspan="1" colspan="1">4.6 [3.5 to 5.6]</td><td align="center" rowspan="1" colspan="1">4.1 [3.2 to 5.1]</td><td align="center" rowspan="1" colspan="1">4.3 [3.3 to 5.3]</td><td align="center" rowspan="1" colspan="1">3.9 [2.9 to 4.9]</td><td align="center" rowspan="1" colspan="1">4.1 [3.1 to 5.2]</td></tr><tr><td align="right" rowspan="1" colspan="1">Month 3</td><td align="center" rowspan="1" colspan="1">3.4 [2.5 to 4.4]</td><td align="center" rowspan="1" colspan="1">3.4 [2.3 to 4.5]</td><td align="center" rowspan="1" colspan="1">3.3 [2.3 to 4.2]</td><td align="center" rowspan="1" colspan="1">3.9 [</td><td align="center" rowspan="1" colspan="1">3.0 [2.1 to 4.0]</td><td align="center" rowspan="1" colspan="1">3.2 [2.2 to 4.2]</td><td align="center" rowspan="1" colspan="1">3.8 [2.8 to 4.8]</td><td align="center" rowspan="1" colspan="1">4.1 [3.0 to 5.1]</td></tr><tr><td align="right" rowspan="1" colspan="1">1 month follow up</td><td align="center" rowspan="1" colspan="1">2.7 [1.8 to 3.6]</td><td align="center" rowspan="1" colspan="1">2.7 [1.6 to 3.8]</td><td align="center" rowspan="1" colspan="1">3.7 [2.8 to 4.7]</td><td align="center" rowspan="1" colspan="1">4.3 [3.2 to 5.4]</td><td align="center" rowspan="1" colspan="1">3.4 [2.5 to 4.4]</td><td align="center" rowspan="1" colspan="1">3.7 [2.7 to 4.6]</td><td align="center" rowspan="1" colspan="1">3.7 [2.8 to 4.8]</td><td align="center" rowspan="1" colspan="1">4.0 [2.9 to 5.0]</td></tr><tr><td align="right" rowspan="1" colspan="1">6 month follow up</td><td align="center" rowspan="1" colspan="1">2.8 [1.9 to 3.8]</td><td align="center" rowspan="1" colspan="1">2.8 [1.8 to 3.9]</td><td align="center" rowspan="1" colspan="1">3.6 [2.6 to 4.5]</td><td align="center" rowspan="1" colspan="1">4.2 [3.1 to 5.2]</td><td align="center" rowspan="1" colspan="1">3.5 [2.5 to 4.5]</td><td align="center" rowspan="1" colspan="1">3.7 [2.7 to 4.7]</td><td align="center" rowspan="1" colspan="1">3.7 [2.8 to 4.7]</td><td align="center" rowspan="1" colspan="1">4.0 [2.9 to 5.0]</td></tr><tr><td align="right" rowspan="1" colspan="1">12 month follow up</td><td align="center" rowspan="1" colspan="1">2.9 [1.9 to 3.9]</td><td align="center" rowspan="1" colspan="1">2.9 [1.8 to 4.0]</td><td align="center" rowspan="1" colspan="1">3.6 [2.6 to 4.5]</td><td align="center" rowspan="1" colspan="1">4.2 [3.1 to 5.2]</td><td align="center" rowspan="1" colspan="1">3.8 [2.8 to 4.7]</td><td align="center" rowspan="1" colspan="1">4.0 [3.0 to 4.9]</td><td align="center" rowspan="1" colspan="1">4.0 [3.0 to 4.9]</td><td align="center" rowspan="1" colspan="1">4.2 [3.2 to 5.3]</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Average Pain</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="right" rowspan="1" colspan="1">Baseline</td><td align="center" rowspan="1" colspan="1">2.4 [1.7 to 3.1]</td><td align="center" rowspan="1" colspan="1">2.6 [1.8 to 3.3]</td><td align="center" rowspan="1" colspan="1">2.7 [2.1 to 3.4]</td><td align="center" rowspan="1" colspan="1">3.3 [2.6 to 4.1]</td><td align="center" rowspan="1" colspan="1">3.2 [2.5 to 3.9]</td><td align="center" rowspan="1" colspan="1">3.5 [2.8 to 4.2]</td><td align="center" rowspan="1" colspan="1">2.6 [1.9 to 3.3]</td><td align="center" rowspan="1" colspan="1">2.9 [2.2 to 3.6]</td></tr><tr><td align="right" rowspan="1" colspan="1">Month 1</td><td align="center" rowspan="1" colspan="1">2.2 [1.5 to 2.9]</td><td align="center" rowspan="1" colspan="1">2.3 [1.6 to 3.1]</td><td align="center" rowspan="1" colspan="1">2.6 [1.9 to 3.3]</td><td align="center" rowspan="1" colspan="1">3.3 [2.5 to 4.0]</td><td align="center" rowspan="1" colspan="1">2.7 [2.1 to 3.4]</td><td align="center" rowspan="1" colspan="1">3.0 [2.4 to 3.7]</td><td align="center" rowspan="1" colspan="1">2.4 [1.7 to 3.1]</td><td align="center" rowspan="1" colspan="1">2.7 [2.0 to 3.4]</td></tr><tr><td align="right" rowspan="1" colspan="1">Month 2</td><td align="center" rowspan="1" colspan="1">2.5 [1.8 to 3.3]</td><td align="center" rowspan="1" colspan="1">2.7 [2.0 to 3.5]</td><td align="center" rowspan="1" colspan="1">2.4 [1.7 to 3.1]</td><td align="center" rowspan="1" colspan="1">3.0 [2.3 to 3.8]</td><td align="center" rowspan="1" colspan="1">2.5 [1.8 to 3.1]</td><td align="center" rowspan="1" colspan="1">2.8 [2.1 to 3.5]</td><td align="center" rowspan="1" colspan="1">2.2 [1.5 to 2.9]</td><td align="center" rowspan="1" colspan="1">2.5 [1.8 to 3.2]</td></tr><tr><td align="right" rowspan="1" colspan="1">Month 3</td><td align="center" rowspan="1" colspan="1">2.1 [1.4 to 2.8]</td><td align="center" rowspan="1" colspan="1">2.3 [1.5 to 3.0]</td><td align="center" rowspan="1" colspan="1">2.0 [1.4 to 2.8]</td><td align="center" rowspan="1" colspan="1">2.7 [1.9 to 3.4]</td><td align="center" rowspan="1" colspan="1">1.7 [1.0 to 2.4]</td><td align="center" rowspan="1" colspan="1">2.0 [1.7 to 3.1]</td><td align="center" rowspan="1" colspan="1">2.2 [1.5 to 3.0]</td><td align="center" rowspan="1" colspan="1">2.5 [1.8 to 3.2]</td></tr><tr><td align="right" rowspan="1" colspan="1">1 month follow up</td><td align="center" rowspan="1" colspan="1">1.6 [1.0 to 2.3]</td><td align="center" rowspan="1" colspan="1">1.8 [1.0 to 2.6]</td><td align="center" rowspan="1" colspan="1">2.3 [1.6 to 3.0]</td><td align="center" rowspan="1" colspan="1">2.9 [2.2 to 3.7]</td><td align="center" rowspan="1" colspan="1">2.0 [1.4 to 2.8]</td><td align="center" rowspan="1" colspan="1">2.4 [1.7 to 3.1]</td><td align="center" rowspan="1" colspan="1">2.2 [1.5 to 3.0]</td><td align="center" rowspan="1" colspan="1">2.6 [1.8 to 3.3]</td></tr><tr><td align="right" rowspan="1" colspan="1">6 month follow up</td><td align="center" rowspan="1" colspan="1">1.6 [0.9 to 2.3]</td><td align="center" rowspan="1" colspan="1">1.7 [1.0 to 2.5]</td><td align="center" rowspan="1" colspan="1">2.3 [1.6 to 3.0]</td><td align="center" rowspan="1" colspan="1">2.9 [2.1 to 3.6]</td><td align="center" rowspan="1" colspan="1">2.0 [1.4 to 2.8]</td><td align="center" rowspan="1" colspan="1">2.3 [1.6 to 3.0]</td><td align="center" rowspan="1" colspan="1">2.2 [1.5 to 3.0]</td><td align="center" rowspan="1" colspan="1">2.5 [1.8 to 3.2]</td></tr><tr><td align="right" rowspan="1" colspan="1">12 month follow up</td><td align="center" rowspan="1" colspan="1">1.8 [1.1 to 2.5]</td><td align="center" rowspan="1" colspan="1">2.0 [1.2 to 2.7]</td><td align="center" rowspan="1" colspan="1">2.3 [1.6 to 3.0]</td><td align="center" rowspan="1" colspan="1">2.9 [2.1 to 3.6]</td><td align="center" rowspan="1" colspan="1">2.3 [1.6 to 3.0]</td><td align="center" rowspan="1" colspan="1">2.6 [1.9 to 3.3]</td><td align="center" rowspan="1" colspan="1">2.4 [1.6 to 3.0]</td><td align="center" rowspan="1" colspan="1">2.7 [1.9 to 3.4]</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Duration of pain (hours per day)</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="right" rowspan="1" colspan="1">Baseline</td><td align="center" rowspan="1" colspan="1">4.0 [1.9 to 6.2]</td><td align="center" rowspan="1" colspan="1">3.0 [0.9 to 5.2]</td><td align="center" rowspan="1" colspan="1">6.6 [4.5 to 8.8]</td><td align="center" rowspan="1" colspan="1">7.4 [5.3 to 9.6]</td><td align="center" rowspan="1" colspan="1">7.0 [4.8 to 9.1]</td><td align="center" rowspan="1" colspan="1">7.0 [5.0 to 9.0]</td><td align="center" rowspan="1" colspan="1">6.5 [4.3 to 8.7]</td><td align="center" rowspan="1" colspan="1">6.5 [4.4 to 8.6]</td></tr><tr><td align="right" rowspan="1" colspan="1">Month 1</td><td align="center" rowspan="1" colspan="1">4.0 [1.7 to 6.1]</td><td align="center" rowspan="1" colspan="1">2.9 [0.8 to 5.1]</td><td align="center" rowspan="1" colspan="1">6.4 [4.3 to 8.6]</td><td align="center" rowspan="1" colspan="1">7.2 [5.1 to 9.4]</td><td align="center" rowspan="1" colspan="1">7.3 [5.2 to 9.5]</td><td align="center" rowspan="1" colspan="1">7.4 [5.4 to 9.4]</td><td align="center" rowspan="1" colspan="1">6.5 [4.4 to 8.8]</td><td align="center" rowspan="1" colspan="1">6.6 [4.5 to 8.8]</td></tr><tr><td align="right" rowspan="1" colspan="1">Month 2</td><td align="center" rowspan="1" colspan="1">3.0 [0.9 to 5.2]</td><td align="center" rowspan="1" colspan="1">2.1 [0.0 to 4.2]</td><td align="center" rowspan="1" colspan="1">6.4 [4.2 to 8.5]</td><td align="center" rowspan="1" colspan="1">7.2 [5.0 to 9.4]</td><td align="center" rowspan="1" colspan="1">5.0 [2.8 to 7.1]</td><td align="center" rowspan="1" colspan="1">5.0 [3.0 to 7.0]</td><td align="center" rowspan="1" colspan="1">5.3 [3.2 to 7.6]</td><td align="center" rowspan="1" colspan="1">5.4 [3.3 to 7.5]</td></tr><tr><td align="right" rowspan="1" colspan="1">Month 3</td><td align="center" rowspan="1" colspan="1">2.9 [0.8 to 5.1]</td><td align="center" rowspan="1" colspan="1">2.0 [0.0 to 4.1]</td><td align="center" rowspan="1" colspan="1">4.0 [1.9 to 6.1]</td><td align="center" rowspan="1" colspan="1">4.8 [2.7 to 7.0]</td><td align="center" rowspan="1" colspan="1">4.2 [3.0 to 6.3]</td><td align="center" rowspan="1" colspan="1">4.2 [2.2 to 6.3]</td><td align="center" rowspan="1" colspan="1">4.6 [2.4 to 6.8]</td><td align="center" rowspan="1" colspan="1">4.6 [2.5 to 6.7]</td></tr><tr><td align="right" rowspan="1" colspan="1">1 month follow up</td><td align="center" rowspan="1" colspan="1">3.1 [0.9 to 5.3]</td><td align="center" rowspan="1" colspan="1">2.1 [0.0 to 4.3]</td><td align="center" rowspan="1" colspan="1">5.2 [3.1 to 7.4]</td><td align="center" rowspan="1" colspan="1">6.0 [3.9 to 8.2]</td><td align="center" rowspan="1" colspan="1">5.2 [3.0 to 7.3]</td><td align="center" rowspan="1" colspan="1">5.2 [3.2 to 7.2]</td><td align="center" rowspan="1" colspan="1">4.0 [1.8 to 6.2]</td><td align="center" rowspan="1" colspan="1">4.1 2.0 to 6.2]</td></tr><tr><td align="right" rowspan="1" colspan="1">6 month follow up</td><td align="center" rowspan="1" colspan="1">3.0 [0.8 to 5.2]</td><td align="center" rowspan="1" colspan="1">2.0 [0.0 to 4.1]</td><td align="center" rowspan="1" colspan="1">5.1 [3.0 to 7.2]</td><td align="center" rowspan="1" colspan="1">6.0 [3.8 to 8.1]</td><td align="center" rowspan="1" colspan="1">5.3 [3.1 to 7.4]</td><td align="center" rowspan="1" colspan="1">5.3 [3.3 to 7.3]</td><td align="center" rowspan="1" colspan="1">4.0 [1.8 to 6.2]</td><td align="center" rowspan="1" colspan="1">4.0 [2.0 to 6.1]</td></tr><tr><td align="right" rowspan="1" colspan="1">12 month follow up</td><td align="center" rowspan="1" colspan="1">3.3 [1.1 to 5.5]</td><td align="center" rowspan="1" colspan="1">2.3 [0.1 to 4.5]</td><td align="center" rowspan="1" colspan="1">4.9 [2.8 to 7.1]</td><td align="center" rowspan="1" colspan="1">5.8 [3.6 to 8.0]</td><td align="center" rowspan="1" colspan="1">5.5 [3.4 to 7.7]</td><td align="center" rowspan="1" colspan="1">5.6 [3.6 to 7.6]</td><td align="center" rowspan="1" colspan="1">4.3 [2.1 to 6.5]</td><td align="center" rowspan="1" colspan="1">4.3 [2.2 to 6.5]</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Analgesic medication (doses per day)</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="right" rowspan="1" colspan="1">Baseline</td><td align="center" rowspan="1" colspan="1">0.52 [0.32 to 0.74]</td><td align="center" rowspan="1" colspan="1">0.34 [0.16 to 0.52]</td><td align="center" rowspan="1" colspan="1">0.7 [0.49 to 0.9]</td><td align="center" rowspan="1" colspan="1">0.55 [0.37 to 0.72]</td><td align="center" rowspan="1" colspan="1">0.47 [0.26 to 0.67]</td><td align="center" rowspan="1" colspan="1">0.38 [0.21 to 0.56]</td><td align="center" rowspan="1" colspan="1">0.51 [0.30 to 0.72]</td><td align="center" rowspan="1" colspan="1">0.43 [0.25 to 0.61]</td></tr><tr><td align="right" rowspan="1" colspan="1">Month 1</td><td align="center" rowspan="1" colspan="1">0.25 [0.05 to 0.47]</td><td align="center" rowspan="1" colspan="1">0.25 [0.07 to 0.43]</td><td align="center" rowspan="1" colspan="1">0.62 [0.41 to 0.82]</td><td align="center" rowspan="1" colspan="1">0.60 [0.43 to 0.78]</td><td align="center" rowspan="1" colspan="1">0.33 [0.13 to 0.54]</td><td align="center" rowspan="1" colspan="1">0.30 [0.12 to 0.48]</td><td align="center" rowspan="1" colspan="1">0.43 [0.21 to 0.64]</td><td align="center" rowspan="1" colspan="1">0.42 [0.24 to 0.60]</td></tr><tr><td align="right" rowspan="1" colspan="1">Month 2</td><td align="center" rowspan="1" colspan="1">0.36 [0.15 to 0.56]</td><td align="center" rowspan="1" colspan="1">0.37 [0.19 to 0.54]</td><td align="center" rowspan="1" colspan="1">0.51 [0.30 to 0.71]</td><td align="center" rowspan="1" colspan="1">0.43 [0.25 to 0.61]</td><td align="center" rowspan="1" colspan="1">0.29 [0.09 to 0.49]</td><td align="center" rowspan="1" colspan="1">0.29 [0.11 to 0.47]</td><td align="center" rowspan="1" colspan="1">0.43 [0.21 to 0.64]</td><td align="center" rowspan="1" colspan="1">0.42 [0.24 to 0.60]</td></tr><tr><td align="right" rowspan="1" colspan="1">Month 3</td><td align="center" rowspan="1" colspan="1">0.34 [0.13 to 0.55]</td><td align="center" rowspan="1" colspan="1">0.28 [0.10 to 0.46]</td><td align="center" rowspan="1" colspan="1">0.46 [0.26 to 0.67]</td><td align="center" rowspan="1" colspan="1">0.40 [0.23 to 0.58]</td><td align="center" rowspan="1" colspan="1">0.25 [0.05 to 0.46]</td><td align="center" rowspan="1" colspan="1">0.21 [0.04 to 0.39]</td><td align="center" rowspan="1" colspan="1">0.38 [0.17 to 0.60]</td><td align="center" rowspan="1" colspan="1">0.39 [0.20 to 0.57]</td></tr><tr><td align="right" rowspan="1" colspan="1">1 month follow up</td><td align="center" rowspan="1" colspan="1">0.28 [0.07 to 0.48]</td><td align="center" rowspan="1" colspan="1">0.22 [0.05 to 0.40]</td><td align="center" rowspan="1" colspan="1">0.58 [0.37 to 0.78]</td><td align="center" rowspan="1" colspan="1">0.51 [0.33 to 0.70]</td><td align="center" rowspan="1" colspan="1">0.27 [0.07 to 0.47]</td><td align="center" rowspan="1" colspan="1">0.26 [0.09 to 0.44]</td><td align="center" rowspan="1" colspan="1">0.44 [0.23 to 0.65]</td><td align="center" rowspan="1" colspan="1">0.43 [0.25 to 0.61]</td></tr><tr><td align="right" rowspan="1" colspan="1">6 month follow up</td><td align="center" rowspan="1" colspan="1">0.36 [0.16 to 0.58]</td><td align="center" rowspan="1" colspan="1">0.28 [0.10 to 0.46]</td><td align="center" rowspan="1" colspan="1">0.55 [0.34 to 0.75]</td><td align="center" rowspan="1" colspan="1">0.50 [0.32 to 0.67]</td><td align="center" rowspan="1" colspan="1">0.27 [0.07 to 0.47]</td><td align="center" rowspan="1" colspan="1">0.26 [0.09 to 0.44]</td><td align="center" rowspan="1" colspan="1">0.47 [0.26 to 0.68]</td><td align="center" rowspan="1" colspan="1">0.45 [0.26 to 0.63]</td></tr><tr><td align="right" rowspan="1" colspan="1">12 month follow up</td><td align="center" rowspan="1" colspan="1">0.48 [0.27 to 0.70]</td><td align="center" rowspan="1" colspan="1">0.36 [0.17 to 0.53]</td><td align="center" rowspan="1" colspan="1">0.54 0[.33 to 0.75]</td><td align="center" rowspan="1" colspan="1">0.49 [0.31 to 0.67]</td><td align="center" rowspan="1" colspan="1">0.31 [0.10 to 0.51]</td><td align="center" rowspan="1" colspan="1">0.29 [0.1 to 0.47]</td><td align="center" rowspan="1" colspan="1">0.58 [0.37 to 0.80]</td><td align="center" rowspan="1" colspan="1">0.52 [0.34 to 0.71]</td></tr></tbody></table></alternatives></table-wrap><sec id="sec016"><title>Primary outcome</title><sec id="sec017"><title>Abdominal pain</title><p>For the primary outcome of peak pain during the first three days of menses at the 12 month follow-up, all groups showed a significant reduction in peak abdominal pain over time, (<italic>F</italic>(6, 1519) = 12.3, p &#x0003c; .0001) and neither mode of stimulation (MA vs EA) (p = 0.48) nor frequency of treatment (LF vs HF) (p = 0.362) showed a significant effect. There was no significant difference between groups (p = 0.597) or any group*time interaction (p = 0.506). A secondary analysis which included baseline co-variates as fixed effects did not significantly alter any of the outcomes.</p></sec></sec><sec id="sec018"><title>Secondary outcomes</title><sec id="sec019"><title>Abdominal pain</title><p>For the secondary outcome of average abdominal pain over the menstrual period all groups showed reductions in average abdominal pain over time (<italic>F</italic>(6, 2324) = 7.98, p &#x0003c; .0001) and neither mode of stimulation (MA vs EA) (p = 0.61) nor frequency of treatment (LF vs HF) (p = 0.74) showed a significant effect. There was no difference between the four groups (p = 0.846) or any group*time interaction (p = 0.105). A secondary analysis with baseline covariates did not significantly alter any of the outcomes.</p></sec><sec id="sec020"><title>Duration of menstrual pain</title><p>For the duration of menstrual pain each day all groups showed reductions in the duration of menstrual pain over time, (<italic>F</italic>(6, 2317) = 12.721, p &#x0003c; .0001) and neither mode of stimulation (MA vs EA) (p = 0.61) nor frequency of treatment (LF vs HF) (p = 0.74) showed a significant effect. There was no significant difference between groups (p = 0.247) or any group*time interaction (p = 0.287). A secondary analysis with baseline covariates did show a difference between groups (<italic>F</italic>(3, 2313) = 3.151, p = 0.024). A post-hoc pairwise analysis showed that the HF-MA group had significantly shorter duration of pain at baseline compared to HF-EA (MD -4.4, 95%CI -7.9 to -1.50, p = 0.003) and LF-MA (MD -3.9, 95%CI -6.9 to 1.0, p = 0.008), at month 1 compared to HF-EA (MD -4.4, 95%CI -7.3 to -1.4, p = 0.004), LF-MA (MD -4.4, 95%CI -7.4 to -1.5, p = 0.003), and LF-EA (MD -3.7, 95%CI -6.6 to -0.8, p = 0.01) and at month 2 compared to HF-EA (MD -5.1, 95%CI -8.1 to -2.2, p = 0.001). This difference was no longer significant from month 3 onwards.</p></sec><sec id="sec021"><title>Analgesic medication</title><p>Medication usage was the mean number of doses per day of menses of analgesic medication. Analgesic medication usage reduced in all groups over time, (<italic>F</italic>(6, 1519) = 3.4, p = 0.002) and mode of stimulation (MA vs EA) showed a significant effect, (<italic>F</italic>(1, 2343) = 5.3, p = 0.02) while frequency of treatment (LF vs HF) did not (p = 0.338). Post-hoc pairwise analysis showed the manual acupuncture groups had lower analgesic intake at month 1 (MD -0.230, 95% CI -0.437 to -0.023, p = 0.03) and 1 month follow-up (MD -0.234, 95% CI MD -0.441 to -0.027, p = 0.027), 6 month follow-up (MD -0.228, 95% CI MD -0.40 to -0.051, p = 0.012) and 12 month follow-up (MD -0.182, 95% CI MD -0.361 to -0.004, p = 0.045). There was no significant difference between groups (p = 0.151) or any group*time interaction (p = 0.921). Secondary analysis which included baseline co-variates as fixed effects did not significantly alter any of the outcomes.</p></sec><sec id="sec022"><title>Secondary symptoms</title><p>There was a decrease in menstrual symptoms over time (<italic>F</italic>(6, 2313) = 8.4, p&#x0003c;0.001) which was different between groups (<italic>F</italic>(18, 2313) = 2.49, p&#x0003c;0.001), see <xref ref-type="fig" rid="pone.0180177.g002">Fig 2</xref>. Mode of stimulation (MA vs EA) showed a significant difference in the number of menstrual symptoms at different time points, (<italic>F</italic>(1, 2320) = 4.2, p&#x0003c;0.001) while frequency of treatment (LF vs HF) did not (p = 0.858). <italic>Post-hoc</italic> pairwise analysis showed that the LF&#x02013;EA group had significantly higher menstrual symptom count at Month Two to all groups, at Month Three compared with HF&#x02013;MA (MD -0.975, 95% CI -1.7 to -0.2, p = 0.005) and LF&#x02013;MA (MD -0.908, 95% CI -0.14 to -1.6, p = 0.011) and at one-month follow-up to HF&#x02013;MA (MD -1.1, 95% CI -0.32 to -1.9, p = 0.001) and LF&#x02013;MA (MD -0.92,95% CI -0.12 to -1.7, p = 0.013). At six and 12-month follow-up the HF-MA group had significantly lower secondary symptom count compared to both HF-EA (MD -1.12, 95% CI -1.9 to -0.30, p = 0.003) and LF-EA (MD -0.956, 95% CI -1.79 to -0.12, p = 0.018).</p><fig id="pone.0180177.g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0180177.g002</object-id><label>Fig 2</label><caption><title>Secondary menstrual symptoms by group over time.</title><p>Error bars are 95% confidence intervals based on estimated margin means.</p></caption><graphic xlink:href="pone.0180177.g002"/></fig></sec><sec id="sec023"><title>Responder rate</title><p>The proportion of responders with clinically significant pain reduction of 30% in their peak pain was highest in the HF&#x02013;MA group across all three days (55%, 60% and 61% of women respectively) and over a third of women in this group had a 70% reduction in their peak pain (See <xref ref-type="table" rid="pone.0180177.t003">Table 3</xref>). Almost three-quarters (72%) of the women in the HF&#x02013;MA group had a clinically significant 30% reduction in their average pain, with 69% of the LF&#x02013;MA group, 61% of the LF&#x02013;EA group and the 47% of the HF&#x02013;EA group achieving this reduction. Almost 60% of the LF&#x02013;MA group and 55% of the HF&#x02013;MA group had a 50% reduction in average pain from baseline to one-month follow-up. The electro-acupuncture groups had lower scores, with 42% and 33% of the HF&#x02013;EA and LF&#x02013;EA groups achieving a 50% reduction.</p><table-wrap id="pone.0180177.t003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0180177.t003</object-id><label>Table 3</label><caption><title>Proportion of responders at each pain-reduction percentage between baseline and follow-up.</title></caption><alternatives><graphic id="pone.0180177.t003g" xlink:href="pone.0180177.t003"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="justify" rowspan="1" colspan="1"/><th align="justify" rowspan="1" colspan="1"/><th align="justify" rowspan="1" colspan="1">Day One</th><th align="justify" rowspan="1" colspan="1"/><th align="justify" rowspan="1" colspan="1"/><th align="justify" rowspan="1" colspan="1">Day Two</th><th align="justify" rowspan="1" colspan="1"/><th align="justify" rowspan="1" colspan="1"/><th align="justify" rowspan="1" colspan="1">Day Three</th><th align="justify" rowspan="1" colspan="1"/></tr><tr><th align="justify" rowspan="1" colspan="1"/><th align="justify" rowspan="1" colspan="1"><italic>30%</italic></th><th align="justify" rowspan="1" colspan="1"><italic>50%</italic></th><th align="justify" rowspan="1" colspan="1"><italic>70%</italic></th><th align="justify" rowspan="1" colspan="1"><italic>30%</italic></th><th align="justify" rowspan="1" colspan="1"><italic>50%</italic></th><th align="justify" rowspan="1" colspan="1"><italic>70%</italic></th><th align="justify" rowspan="1" colspan="1"><italic>30%</italic></th><th align="justify" rowspan="1" colspan="1"><italic>50%</italic></th><th align="justify" rowspan="1" colspan="1"><italic>70%</italic></th></tr></thead><tbody><tr><td align="justify" rowspan="1" colspan="1"><bold>HF&#x02013;MA</bold></td><td align="justify" rowspan="1" colspan="1">55.6%</td><td align="justify" rowspan="1" colspan="1">50.0%</td><td align="justify" rowspan="1" colspan="1">38.9%</td><td align="justify" rowspan="1" colspan="1">61.1%</td><td align="justify" rowspan="1" colspan="1">44.4%</td><td align="justify" rowspan="1" colspan="1">38.9%</td><td align="justify" rowspan="1" colspan="1">61.1%</td><td align="justify" rowspan="1" colspan="1">50.0%</td><td align="justify" rowspan="1" colspan="1">38.9%</td></tr><tr><td align="justify" rowspan="1" colspan="1"><bold>HF&#x02013;EA</bold></td><td align="justify" rowspan="1" colspan="1">36.8%</td><td align="justify" rowspan="1" colspan="1">26.3%</td><td align="justify" rowspan="1" colspan="1">21.1%</td><td align="justify" rowspan="1" colspan="1">42.1%</td><td align="justify" rowspan="1" colspan="1">31.6%</td><td align="justify" rowspan="1" colspan="1">26.3%</td><td align="justify" rowspan="1" colspan="1">47.4%</td><td align="justify" rowspan="1" colspan="1">47.4%</td><td align="justify" rowspan="1" colspan="1">42.1%</td></tr><tr><td align="justify" rowspan="1" colspan="1"><bold>LF&#x02013;MA</bold></td><td align="justify" rowspan="1" colspan="1">52.6%</td><td align="justify" rowspan="1" colspan="1">26.3%</td><td align="justify" rowspan="1" colspan="1">15.8%</td><td align="justify" rowspan="1" colspan="1">42.1%</td><td align="justify" rowspan="1" colspan="1">31.6%</td><td align="justify" rowspan="1" colspan="1">15.8%</td><td align="justify" rowspan="1" colspan="1">52.6%</td><td align="justify" rowspan="1" colspan="1">47.4%</td><td align="justify" rowspan="1" colspan="1">36.8%</td></tr><tr><td align="justify" rowspan="1" colspan="1"><bold>LF&#x02013;EA</bold></td><td align="justify" rowspan="1" colspan="1">50.0%</td><td align="justify" rowspan="1" colspan="1">44.4%</td><td align="justify" rowspan="1" colspan="1">27.8%</td><td align="justify" rowspan="1" colspan="1">38.9%</td><td align="justify" rowspan="1" colspan="1">27.8%</td><td align="justify" rowspan="1" colspan="1">22.2%</td><td align="justify" rowspan="1" colspan="1">16.7%</td><td align="justify" rowspan="1" colspan="1">11.1%</td><td align="justify" rowspan="1" colspan="1">5.6%</td></tr></tbody></table></alternatives></table-wrap></sec><sec id="sec024"><title>Health-related quality of life (SF-36v2)</title><p>Overall, both the high-frequency groups showed a greater number of improvements in the SF-36 domains (six domains) compared to the low-frequency groups (two domains). Health related quality of life measured by the SF-36 improved across a number of domains, between baseline and one-month follow-up (see <xref ref-type="table" rid="pone.0180177.t004">Table 4</xref>). Paired t-tests showed that there were improvements in the domains of role physical (p = 0.0029), bodily pain (p = 0.0002), vitality (p = 0.028), social function (p = 0.0067) and overall physical component (p = 0.001) between baseline and one-month follow-up. A one-way ANOVA showed no difference between groups at the one month follow-up time point.</p><table-wrap id="pone.0180177.t004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0180177.t004</object-id><label>Table 4</label><caption><title>SF-36 scores at one-month follow-up.</title></caption><alternatives><graphic id="pone.0180177.t004g" xlink:href="pone.0180177.t004"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">HF&#x02013;MA (n = 18)</th><th align="left" rowspan="1" colspan="1">HF&#x02013;EA (n = 19)</th><th align="left" rowspan="1" colspan="1">LF&#x02013;MA (n = 17)</th><th align="left" rowspan="1" colspan="1">LF&#x02013;EA (n = 15)</th><th align="left" rowspan="1" colspan="1">Total (n = 69)</th><th align="left" rowspan="1" colspan="1"/></tr><tr><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">mean (SD)</th><th align="left" rowspan="1" colspan="1">mean (SD)</th><th align="left" rowspan="1" colspan="1">mean (SD)</th><th align="left" rowspan="1" colspan="1">mean (SD)</th><th align="left" rowspan="1" colspan="1">mean (SD)</th><th align="left" rowspan="1" colspan="1">p-value (baseline to follow-up)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Physical function</td><td align="left" rowspan="1" colspan="1">55.6 (2.6)</td><td align="left" rowspan="1" colspan="1">56.2 (1.2)</td><td align="left" rowspan="1" colspan="1">53.3 (5.1)</td><td align="left" rowspan="1" colspan="1">55.6 (3.5)</td><td align="left" rowspan="1" colspan="1">55.2 (3.5)</td><td align="left" rowspan="1" colspan="1">0.207</td></tr><tr><td align="left" rowspan="1" colspan="1">Role physical</td><td align="left" rowspan="1" colspan="1">54.2 (5.0)</td><td align="left" rowspan="1" colspan="1">50.7 (6.7)<xref ref-type="table-fn" rid="t004fn001">*</xref></td><td align="left" rowspan="1" colspan="1">52.1 (4.4)</td><td align="left" rowspan="1" colspan="1">49.9 (6.8)</td><td align="left" rowspan="1" colspan="1">51.8 (5.9)</td><td align="left" rowspan="1" colspan="1">0.0029<xref ref-type="table-fn" rid="t004fn001">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Bodily pain</td><td align="left" rowspan="1" colspan="1">50.7 (6.4)</td><td align="left" rowspan="1" colspan="1">48.7 (9.0)<xref ref-type="table-fn" rid="t004fn001">*</xref></td><td align="left" rowspan="1" colspan="1">48.0 (7.4)<xref ref-type="table-fn" rid="t004fn001">*</xref></td><td align="left" rowspan="1" colspan="1">47.2 (6.7)</td><td align="left" rowspan="1" colspan="1">48.7 (7.4)</td><td align="left" rowspan="1" colspan="1">0.0002<xref ref-type="table-fn" rid="t004fn001">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">General health</td><td align="left" rowspan="1" colspan="1">52.8 (11.2)</td><td align="left" rowspan="1" colspan="1">51.7 (9.1)</td><td align="left" rowspan="1" colspan="1">52.99 (7.9)</td><td align="left" rowspan="1" colspan="1">53.4 (7.9)</td><td align="left" rowspan="1" colspan="1">53.0 (9.0)</td><td align="left" rowspan="1" colspan="1">0.12</td></tr><tr><td align="left" rowspan="1" colspan="1">Vitality</td><td align="left" rowspan="1" colspan="1">52.7 (8.3)<xref ref-type="table-fn" rid="t004fn001">*</xref></td><td align="left" rowspan="1" colspan="1">47.6 (8.9)</td><td align="left" rowspan="1" colspan="1">49.8 (10.8)</td><td align="left" rowspan="1" colspan="1">47.4 (9.5)</td><td align="left" rowspan="1" colspan="1">49.5 (9.4)</td><td align="left" rowspan="1" colspan="1">0.028<xref ref-type="table-fn" rid="t004fn001">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Social function</td><td align="left" rowspan="1" colspan="1">53.9 (7.0)<xref ref-type="table-fn" rid="t004fn001">*</xref></td><td align="left" rowspan="1" colspan="1">48.6 (10.0)<xref ref-type="table-fn" rid="t004fn001">*</xref></td><td align="left" rowspan="1" colspan="1">47.3 (9.2)</td><td align="left" rowspan="1" colspan="1">46.6 (6.7)</td><td align="left" rowspan="1" colspan="1">49.2 (8.7)</td><td align="left" rowspan="1" colspan="1">0.0067<xref ref-type="table-fn" rid="t004fn001">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Role emotional</td><td align="left" rowspan="1" colspan="1">50.7 (7.2)</td><td align="left" rowspan="1" colspan="1">47.9 (7.8)</td><td align="left" rowspan="1" colspan="1">48.6 (9.9)</td><td align="left" rowspan="1" colspan="1">47.5 (8.4)</td><td align="left" rowspan="1" colspan="1">48.75 (8.4)</td><td align="left" rowspan="1" colspan="1">0.209</td></tr><tr><td align="left" rowspan="1" colspan="1">Mental health</td><td align="left" rowspan="1" colspan="1">51.3 (7.6)</td><td align="left" rowspan="1" colspan="1">51.2 (7.2)</td><td align="left" rowspan="1" colspan="1">48.8 (10.7)</td><td align="left" rowspan="1" colspan="1">49.2 (8.6)</td><td align="left" rowspan="1" colspan="1">50.2 (8.5)</td><td align="left" rowspan="1" colspan="1">0.267</td></tr><tr><td align="left" rowspan="1" colspan="1">Overall mental component</td><td align="left" rowspan="1" colspan="1">50.6 (9.6)<xref ref-type="table-fn" rid="t004fn001">*</xref></td><td align="left" rowspan="1" colspan="1">47.3 (9.5)</td><td align="left" rowspan="1" colspan="1">47.1 (12.2)</td><td align="left" rowspan="1" colspan="1">46.0 (9.3)</td><td align="left" rowspan="1" colspan="1">47.89 (10.1)</td><td align="left" rowspan="1" colspan="1">0.142</td></tr><tr><td align="left" rowspan="1" colspan="1">Overall physical component</td><td align="left" rowspan="1" colspan="1">54.5 (5.8)</td><td align="left" rowspan="1" colspan="1">53.1 (5.2)<xref ref-type="table-fn" rid="t004fn001">*</xref></td><td align="left" rowspan="1" colspan="1">52.8 (6.7)</td><td align="left" rowspan="1" colspan="1">52.9 (6.8)<xref ref-type="table-fn" rid="t004fn001">*</xref></td><td align="left" rowspan="1" colspan="1">53.3 (6.0)</td><td align="left" rowspan="1" colspan="1">0.001<xref ref-type="table-fn" rid="t004fn001">*</xref></td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t004fn001"><p>* indicates significant change between baseline and one-month follow-up.</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec025"><title>Self-rated symptom improvement</title><p>At the end of the intervention the mean self-rated improvement score by group was HF&#x02013;MA 7.4 (95% CI 6.13 to 8.67), HF&#x02013;EA 6.75 (95% CI 5.15 to 8.35), LF&#x02013;MA 7.47 (95% CI 6.44 to 8.50), and LF&#x02013;EA 6.5 (95% CI 5.07 to 7.93). Overall self-rated improvement score, independent of group was 7.05 (95% CI 6.43 to 7.67). A one-way ANOVA showed no difference between groups in self-rated improvement (F(3,58) = .577, p = 0.632). Participants were asked to list the symptoms, if any, that they thought improved the most during the trial. Women reported that abdominal cramps were the most common symptom to improve, with 36 women indicating abdominal pain or cramping showed significant improvement. Emotional changes (13 women) and back and leg pain (15 women) were also commonly reported improvements.</p></sec><sec id="sec026"><title>Safety</title><p>Fifty-two adverse events (AE) occurred over 702 acupuncture sessions, giving an overall adverse event rate of 7.4% (95% CI 5.6 to 9.6) (see <xref ref-type="table" rid="pone.0180177.t005">Table 5</xref>). There was no difference in AE rate between groups. Most of the events were minor and self-limiting. Bruising (haematoma) was the most common adverse event (50% of all AE or 3.7% of treatments) with post treatment soreness occurring in 1.4% of treatments and fatigue in 1.1% of treatments.</p><table-wrap id="pone.0180177.t005" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0180177.t005</object-id><label>Table 5</label><caption><title>Adverse events during the treatment period.</title></caption><alternatives><graphic id="pone.0180177.t005g" xlink:href="pone.0180177.t005"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Adverse event</th><th align="left" rowspan="1" colspan="1">% of total treatments (95% CI)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Bruising</td><td align="left" rowspan="1" colspan="1">3.7% [2.5 to 5.3]</td></tr><tr><td align="left" rowspan="1" colspan="1">Post-treatment soreness</td><td align="left" rowspan="1" colspan="1">1.4% [0.74 to 2.6]</td></tr><tr><td align="left" rowspan="1" colspan="1">Fatigue</td><td align="left" rowspan="1" colspan="1">1.1% [0.54 to 2.2]</td></tr><tr><td align="left" rowspan="1" colspan="1">Feeling faint</td><td align="left" rowspan="1" colspan="1">0.28% [0.1 to 1.1]</td></tr><tr><td align="left" rowspan="1" colspan="1">Itching</td><td align="left" rowspan="1" colspan="1">0.14% [0.1 to 0.89]</td></tr><tr><td align="left" rowspan="1" colspan="1">Bowel changes</td><td align="left" rowspan="1" colspan="1">0.14% [0.1 to 0.89]</td></tr><tr><td align="left" rowspan="1" colspan="1">Burns</td><td align="left" rowspan="1" colspan="1">0.14% [0.1 to 0.89]</td></tr></tbody></table></alternatives></table-wrap></sec></sec></sec><sec sec-type="conclusions" id="sec027"><title>Discussion</title><p>Acupuncture treatment, regardless of group, using a manualised acupuncture protocol, showed significant clinical improvements in all menstrual pain scores recorded; &#x02018;peak pain&#x02019; over the first three days of the menstrual period and &#x02018;average pain&#x02019; over the entire menstrual period, and that reduction was sustained for twelve months. This was supported by a similar significant reduction across all other measures of menstrual impact; duration of pain, analgesic usage, secondary menstrual symptoms and a high self-rated improvement score. Electro-acupuncture did not deliver greater pain reduction than manual acupuncture. Manual acupuncture groups tended to have a higher responder rate, significantly greater reduction in secondary symptoms, and lower analgesic usage. With respect to health related quality of life six domains improved from baseline in the HF groups, with only two improving from baseline in the LF groups. There was no difference between manual and electro-acupuncture in terms of domains improved.</p><p>The lack of superiority of electro-acupuncture in terms of pain reduction was unexpected. Electro-acupuncture in the trial was delivered at a 2/100Hz frequency, which has been shown to provide maximal opioid gene expression by combining both high and low frequencies to provide maximal pain relief[<xref rid="pone.0180177.ref046" ref-type="bibr">46</xref>]. This high frequency&#x02013;low frequency stimulation pattern is very common in gynaecological disorders[<xref rid="pone.0180177.ref047" ref-type="bibr">47</xref>], and is identical to the frequency used in many other trials of electro-acupuncture for primary dysmenorrhea[<xref rid="pone.0180177.ref048" ref-type="bibr">48</xref>&#x02013;<xref rid="pone.0180177.ref051" ref-type="bibr">51</xref>]. Animal models suggest that needling at REN4, SP8 and SP6, used in 80%, 55% and 98% of all study treatments respectively, regulates neuro-endocrine activities, including levels of progesterone[<xref rid="pone.0180177.ref052" ref-type="bibr">52</xref>]; and needling SP6 has been shown to increase ovarian blood flow via a reflex response in rats[<xref rid="pone.0180177.ref053" ref-type="bibr">53</xref>]. A similar reflex response exists in humans, increasing uterine blood flow by reducing sympathetic activity on vasoconstrictor fibres that innervate the uterus[<xref rid="pone.0180177.ref025" ref-type="bibr">25</xref>, <xref rid="pone.0180177.ref054" ref-type="bibr">54</xref>]. Uterine blood flow is often reduced in women with primary dysmenorrhea[<xref rid="pone.0180177.ref055" ref-type="bibr">55</xref>, <xref rid="pone.0180177.ref056" ref-type="bibr">56</xref>] and increasing uterine blood flow appears to be related to some of the analgesic benefits of acupuncture in primary dysmenorrhea[<xref rid="pone.0180177.ref050" ref-type="bibr">50</xref>, <xref rid="pone.0180177.ref057" ref-type="bibr">57</xref>]. The magnitude of the impact of needling SP6 and, to a lesser extent, REN4 and SP8, may be larger than stimulation-specific differences. Another plausible possibility is that the time course of increased endogenous opioid release caused by electro-acupuncture is too short to contribute to a noticeable overall reduction in menstrual pain [<xref rid="pone.0180177.ref058" ref-type="bibr">58</xref>].</p><p>In addition to reductions in pain, many women had a reduction in their secondary menstrual symptoms. Inflammation is a primary cause of primary dysmenorrhea [<xref rid="pone.0180177.ref059" ref-type="bibr">59</xref>] and a possible cause of PMS symptoms, including mood changes, bloating and breast tenderness [<xref rid="pone.0180177.ref060" ref-type="bibr">60</xref>]. The wide range of improvements in both pain and PMS related symptoms, especially mood changes, seen in this trial provide support for acupuncture&#x02019;s posited anti-inflammatory effects[<xref rid="pone.0180177.ref024" ref-type="bibr">24</xref>], future research including suitable bio-makers would provide more information on these possible pathways.</p><p>Analgesic medication usage was lower amongst the manual acupuncture groups. As analgesic usage was allowed <italic>ad libitum</italic> women may have used analgesic medication to achieve an acceptable level of pain. Therefore, the lower usage of analgesic medication amongst these two groups suggests that without analgesic usage there may have been more pronounced differences between these two groups. The reasons for this lower use are unclear, as electro-acupuncture should provide at least the same amount of relief as manual acupuncture, as the needles were stimulated to obtain DeQi prior to electro-stimulation, thereby delivering a manual acupuncture-like stimulus prior to the addition of the electro-acupuncture pulse[<xref rid="pone.0180177.ref061" ref-type="bibr">61</xref>]. The changes in the HRQoL SF-36 domains suggest that after the course of acupuncture treatment, participants had less problems with work or daily activities as a result of their physical health, less pain and subsequent limitations due to pain, more energy, and less interference from physical and emotional problems in social activities[<xref rid="pone.0180177.ref062" ref-type="bibr">62</xref>], all of which are commonly experienced by women with primary dysmenorrhea [<xref rid="pone.0180177.ref008" ref-type="bibr">8</xref>, <xref rid="pone.0180177.ref063" ref-type="bibr">63</xref>].</p><p>In terms of pain reduction, the trial findings were similar to results provided by previous studies. Direct comparison to studies performed in China[<xref rid="pone.0180177.ref029" ref-type="bibr">29</xref>, <xref rid="pone.0180177.ref048" ref-type="bibr">48</xref>&#x02013;<xref rid="pone.0180177.ref051" ref-type="bibr">51</xref>] with very short timescales of measurement post-treatment are problematic as these may not represent meaningful changes over the entire menses. Comparisons with other trials outside of China tend to show similar results to this study. Absolute pain reductions were less than Witt (Germany)[<xref rid="pone.0180177.ref045" ref-type="bibr">45</xref>] and Helms (US) [<xref rid="pone.0180177.ref064" ref-type="bibr">64</xref>] but similar to that found by Smith (Australia)[<xref rid="pone.0180177.ref044" ref-type="bibr">44</xref>]. Comparison with Helms [<xref rid="pone.0180177.ref064" ref-type="bibr">64</xref>] is complicated by the fact that the sample size was very small, showing no between group differences and the use of a custom pain scale that was not validated. The greater absolute pain reduction found by Witt [<xref rid="pone.0180177.ref045" ref-type="bibr">45</xref>] may be due to the nature of the intervention, where physicians were allowed to choose treatment without restriction, or due to the greater sample size, almost ten times the size of this study. However, the responder rates (&#x0003e;30% reduction in average pain from baseline) were similar to Witt&#x02019;s, showing that the percentage pain reduction from baseline was relatively equal between the two studies. Similarly to Smith [<xref rid="pone.0180177.ref044" ref-type="bibr">44</xref>] and Witt [<xref rid="pone.0180177.ref045" ref-type="bibr">45</xref>], reductions in pain in this study appeared to be sustained or increased after the trial period ended.</p><p>There were no between group differences in all pain outcome measures, despite large differences in responder rates between groups. This is most likely due to the exploratory nature of the study, which was not powered to detect small between group differences. A <italic>post-hoc</italic> power analysis shows that a sample size of 192 would be required to determine a 20% difference between groups for average pain. While a difference of &#x0003e;30% from baseline is considered clinically important, the size of differences between groups that are important to participants appears to be dependent on the condition treated[<xref rid="pone.0180177.ref043" ref-type="bibr">43</xref>]. In this case, these between group differences do not appear to significantly alter how successful women felt their treatment was, supported by the fact there was no difference in self-reported improvement score between groups, however, future studies with significantly more participants would be required to answer this question.</p><p>The strengths of this exploratory study were that it recruited a group of participants who were representative of women in the community with dysmenorrhea, having a variety of secondary symptoms, including back pain, fatigue, breast tenderness, nausea, headaches and bowel changes, consistent with many other populations with primary dysmenorrhea[<xref rid="pone.0180177.ref008" ref-type="bibr">8</xref>, <xref rid="pone.0180177.ref009" ref-type="bibr">9</xref>, <xref rid="pone.0180177.ref034" ref-type="bibr">34</xref>]. Analgesic usage amongst the study participants was very prevalent (81%), almost identical to the prevalence of analgesic usage in Australian women with dysmenorrhea (80%)[<xref rid="pone.0180177.ref065" ref-type="bibr">65</xref>]. There are several limitations on this exploratory study: Due to the high loss to follow-up at 6 and 12 months the significant use of last observation carried forward in a small sample such as this could contribute to over-estimating the duration of the treatment effect in the intention to treat analysis, however a per-protocol analysis without using last observation carried forward showed similar results. The RCT, due to its design in comparing effectiveness of differing doses of acupuncture, did not have a usual care group. The changes observed over the 12 month period are unlikely to be due to natural reductions in the pain from primary dysmenorrhea[<xref rid="pone.0180177.ref066" ref-type="bibr">66</xref>]. Witt (Germany) [<xref rid="pone.0180177.ref045" ref-type="bibr">45</xref>] showed a 15% reduction in average menstrual pain in the usual care group at 3 months while our study found a 24% reduction in average pain independent of group allocation at the same time point. This suggests an additional benefit of acupuncture but our ability to determine the extent to which acupuncture treatment is responsible for the changes in pain, menstrual symptoms and health-related quality of life observed in the study is limited.</p></sec><sec sec-type="conclusions" id="sec028"><title>Conclusion</title><p>This exploratory study suggests acupuncture administered over three menstrual cycles gave both statistically and clinically significant reductions in menstrual pain compared to baseline and persisted for 12 months, however there was no significant difference in pain intensity between groups. Electro-acupuncture was well tolerated but did not always provide the same magnitude of improvements as manual acupuncture in reducing secondary menstrual symptoms and analgesic medication intake. Manual acupuncture provided the same or greater pain relief as electro-acupuncture, but with less analgesic medication required to achieve this pain reduction. Treatment timing appears to play a small role, with high frequency of treatment providing greater improvements in health-related quality of life. This exploratory trial suggests that there may be an effect of both treatment timing and mode of stimulation, but possibly only of small clinical benefit. Future adequately powered studies are needed to confirm the role of both mode of stimulation and treatment timing and to provide a more accurate indication of the clinical impact of altering these dose components on menstrual pain.</p></sec><sec sec-type="supplementary-material" id="sec029"><title>Supporting information</title><supplementary-material content-type="local-data" id="pone.0180177.s001"><label>S1 Fig</label><caption><title>Diagnosis and point selection.</title><p>(DOCX)</p></caption><media xlink:href="pone.0180177.s001.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0180177.s002"><label>S1 File</label><caption><title>Manualised acupuncture trial protocol.</title><p>(PDF)</p></caption><media xlink:href="pone.0180177.s002.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0180177.s003"><label>S2 File</label><caption><title>Menstrual pain diary.</title><p>(PDF)</p></caption><media xlink:href="pone.0180177.s003.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0180177.s004"><label>S3 File</label><caption><title>Trial exit questionnaire.</title><p>(PDF)</p></caption><media xlink:href="pone.0180177.s004.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0180177.s005"><label>S4 File</label><caption><title>Per protocol analysis.</title><p>(DOCX)</p></caption><media xlink:href="pone.0180177.s005.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0180177.s006"><label>S1 Consort Checklist</label><caption><p>(DOC)</p></caption><media xlink:href="pone.0180177.s006.doc"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0180177.s007"><label>S1 Appendix</label><caption><title>Protocol for the RCT.</title><p>(DOCX)</p></caption><media xlink:href="pone.0180177.s007.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0180177.s008"><label>S2 Appendix</label><caption><title>Data analysis file ITT (SPSS).</title><p>(SAV)</p></caption><media xlink:href="pone.0180177.s008.sav"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0180177.s009"><label>S3 Appendix</label><caption><title>Data analysis file PP (SPSS).</title><p>(SAV)</p></caption><media xlink:href="pone.0180177.s009.sav"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0180177.s010"><label>S4 Appendix</label><caption><title>Model fit data.</title><p>(XLSX)</p></caption><media xlink:href="pone.0180177.s010.xlsx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0180177.s011"><label>S5 Appendix</label><caption><title>Raw SF-36 data.</title><p>(XLSX)</p></caption><media xlink:href="pone.0180177.s011.xlsx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0180177.s012"><label>S6 Appendix</label><caption><title>Demographic dataset.</title><p>(SAV)</p></caption><media xlink:href="pone.0180177.s012.sav"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>Thanks to Dr Kingsley Agho, Dr Avinesh Pillai, Dr Haider Mannan and Mr Paul Fahey for their statistical advice, Dr Debra Betts, Ms Kate Roberts and Ms Serena Joe for their assistance with organising and delivering the trial intervention, Brendon Hooker and Julian Cloete for the use of the treatment space, all of the staff at NICM and all the women who participated in this study.</p></ack><ref-list><title>References</title><ref id="pone.0180177.ref001"><label>1</label><mixed-citation publication-type="journal"><name><surname>Proctor</surname><given-names>M</given-names></name>, <name><surname>Farquhar</surname><given-names>C</given-names></name>. <article-title>Diagnosis and management of dysmenorrhoea</article-title>. <source>BMJ</source>. <year>2006</year>;<volume>332</volume>(<issue>7550</issue>):<fpage>1134</fpage>&#x02013;<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1136/bmj.332.7550.1134">10.1136/bmj.332.7550.1134</ext-link></comment>
<pub-id pub-id-type="pmid">16690671</pub-id></mixed-citation></ref><ref id="pone.0180177.ref002"><label>2</label><mixed-citation publication-type="journal"><name><surname>Wong</surname><given-names>CL</given-names></name>, <name><surname>Farquhar</surname><given-names>C</given-names></name>, <name><surname>Roberts</surname><given-names>H</given-names></name>, <name><surname>Proctor</surname><given-names>M</given-names></name>. <article-title>Oral contraceptive pill for primary dysmenorrhoea</article-title>. <source>Cochrane Database Syst Rev</source>. <year>2009</year>(<issue>4</issue>):<fpage>CD002120</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/14651858.CD002120.pub3">10.1002/14651858.CD002120.pub3</ext-link></comment>
<pub-id pub-id-type="pmid">19821293</pub-id></mixed-citation></ref><ref id="pone.0180177.ref003"><label>3</label><mixed-citation publication-type="journal"><name><surname>Latthe</surname><given-names>P</given-names></name>, <name><surname>Latthe</surname><given-names>M</given-names></name>, <name><surname>Say</surname><given-names>L</given-names></name>, <name><surname>G&#x000fc;lmezoglu</surname><given-names>M</given-names></name>, <name><surname>Khan</surname><given-names>KS</given-names></name>. <article-title>WHO systematic review of prevalence of chronic pelvic pain: a neglected reproductive health morbidity</article-title>. <source>BMC Public Health</source>. <year>2006</year>;<volume>6</volume>:<fpage>177</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/1471-2458-6-177">10.1186/1471-2458-6-177</ext-link></comment>
<pub-id pub-id-type="pmid">16824213</pub-id></mixed-citation></ref><ref id="pone.0180177.ref004"><label>4</label><mixed-citation publication-type="journal"><name><surname>Pitts</surname><given-names>MK</given-names></name>, <name><surname>Ferris</surname><given-names>JA</given-names></name>, <name><surname>Smith</surname><given-names>AM</given-names></name>, <name><surname>Shelley</surname><given-names>JM</given-names></name>, <name><surname>Richters</surname><given-names>J</given-names></name>. <article-title>Prevalence and correlates of three types of pelvic pain in a nationally representative sample of Australian women</article-title>. <source>Med J Aust</source>. <year>2008</year>;<volume>189</volume>(<issue>3</issue>):<fpage>138</fpage>&#x02013;<lpage>43</lpage>. <pub-id pub-id-type="pmid">18673099</pub-id></mixed-citation></ref><ref id="pone.0180177.ref005"><label>5</label><mixed-citation publication-type="journal"><name><surname>Davis</surname><given-names>AR</given-names></name>, <name><surname>Westhoff</surname><given-names>CL</given-names></name>. <article-title>Primary dysmenorrhea in adolescent girls and treatment with oral contraceptives</article-title>. <source>J Pediatr Adolesc Gynecol</source>. <year>2001</year>;<volume>14</volume>(<issue>1</issue>):<fpage>3</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="pmid">11358700</pub-id></mixed-citation></ref><ref id="pone.0180177.ref006"><label>6</label><mixed-citation publication-type="journal"><name><surname>Zahradnik</surname><given-names>H-P</given-names></name>, <name><surname>Hanjalic-Beck</surname><given-names>A</given-names></name>, <name><surname>Groth</surname><given-names>K</given-names></name>. <article-title>Nonsteroidal anti-inflammatory drugs and hormonal contraceptives for pain relief from dysmenorrhea: a review</article-title>. <source>Contraception</source>. <year>2010</year>;<volume>81</volume>(<issue>3</issue>):<fpage>185</fpage>&#x02013;<lpage>96</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.contraception.2009.09.014">10.1016/j.contraception.2009.09.014</ext-link></comment>
<pub-id pub-id-type="pmid">20159173</pub-id></mixed-citation></ref><ref id="pone.0180177.ref007"><label>7</label><mixed-citation publication-type="journal"><name><surname>Andersch</surname><given-names>B</given-names></name>, <name><surname>Milsom</surname><given-names>I</given-names></name>. <article-title>An epidemiologic study of young women with dysmenorrhea</article-title>. <source>Am J Obstet Gynecol</source>. <year>1982</year>;<volume>144</volume>(<issue>6</issue>):<fpage>655</fpage>&#x02013;<lpage>60</lpage>. <pub-id pub-id-type="pmid">7137249</pub-id></mixed-citation></ref><ref id="pone.0180177.ref008"><label>8</label><mixed-citation publication-type="journal"><name><surname>Banikarim</surname><given-names>C</given-names></name>, <name><surname>Chacko</surname><given-names>MR</given-names></name>, <name><surname>Kelder</surname><given-names>SH</given-names></name>. <article-title>Prevalence and impact of dysmenorrhea on hispanic female adolescents</article-title>. <source>Arch Pediatr Adolesc Med</source>. <year>2000</year>;<volume>154</volume>(<issue>12</issue>):<fpage>1226</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="pmid">11115307</pub-id></mixed-citation></ref><ref id="pone.0180177.ref009"><label>9</label><mixed-citation publication-type="journal"><name><surname>Hillen</surname><given-names>TI</given-names></name>, <name><surname>Grbavac</surname><given-names>SL</given-names></name>, <name><surname>Johnston</surname><given-names>PJ</given-names></name>, <name><surname>Straton</surname><given-names>JA</given-names></name>, <name><surname>Keogh</surname><given-names>JM</given-names></name>. <article-title>Primary dysmenorrhea in young western australian women: prevalence, impact, and knowledge of treatment</article-title>. <source>Journal of Adolescent Health</source>. <year>1999</year>;<volume>25</volume>(<issue>1</issue>):<fpage>40</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="pmid">10418884</pub-id></mixed-citation></ref><ref id="pone.0180177.ref010"><label>10</label><mixed-citation publication-type="journal"><name><surname>Campbell</surname><given-names>MA</given-names></name>, <name><surname>McGrath</surname><given-names>PJ</given-names></name>. <article-title>Use of medication by adolescents for the management of menstrual discomfort</article-title>. <source>Arch Pediatr Adolesc Med</source>. <year>1997</year>;<volume>151</volume>(<issue>9</issue>):<fpage>905</fpage>&#x02013;<lpage>13</lpage>. <pub-id pub-id-type="pmid">9308868</pub-id></mixed-citation></ref><ref id="pone.0180177.ref011"><label>11</label><mixed-citation publication-type="journal"><name><surname>Jamieson</surname><given-names>DJ</given-names></name>, <name><surname>Steege</surname><given-names>JF</given-names></name>. <article-title>The prevalence of dysmenorrhea, dyspareunia, pelvic pain, and irritable bowel syndrome in primary care practices</article-title>. <source>Obstet Gynecol</source>. <year>1996</year>;<volume>87</volume>(<issue>1</issue>):<fpage>55</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="pmid">8532266</pub-id></mixed-citation></ref><ref id="pone.0180177.ref012"><label>12</label><mixed-citation publication-type="journal"><name><surname>Armour</surname><given-names>M</given-names></name>, <name><surname>Dahlen</surname><given-names>HG</given-names></name>, <name><surname>Smith</surname><given-names>CA</given-names></name>. <article-title>More Than Needles: The Importance of Explanations and Self-Care Advice in Treating Primary Dysmenorrhea with Acupuncture</article-title>. <source>Evid Based Complement Alternat Med</source>. <year>2016</year>;<volume>2016</volume>:3467067. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1155/2016/3467067">10.1155/2016/3467067</ext-link></comment>
<pub-id pub-id-type="pmid">27242909</pub-id></mixed-citation></ref><ref id="pone.0180177.ref013"><label>13</label><mixed-citation publication-type="journal"><name><surname>Marjoribanks</surname><given-names>J</given-names></name>, <name><surname>Proctor</surname><given-names>M</given-names></name>, <name><surname>Farquhar</surname><given-names>C</given-names></name>, <name><surname>Derks</surname><given-names>RS</given-names></name>. <article-title>Nonsteroidal anti-inflammatory drugs for dysmenorrhoea</article-title>. <source>Cochrane Database Syst Rev</source>. <year>2010</year>(<issue>1</issue>):<fpage>CD001751</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/14651858.CD001751.pub2">10.1002/14651858.CD001751.pub2</ext-link></comment>
<pub-id pub-id-type="pmid">20091521</pub-id></mixed-citation></ref><ref id="pone.0180177.ref014"><label>14</label><mixed-citation publication-type="book"><name><surname>Howard</surname><given-names>F</given-names></name>, <name><surname>Perry</surname><given-names>P</given-names></name>, <name><surname>Carter</surname><given-names>J</given-names></name>, <name><surname>El-Minawi</surname><given-names>A</given-names></name>. <source>Pelvic Pain: diagnosis and management</source>. <publisher-loc>Philadelphia</publisher-loc>: <publisher-name>Lippincott Williams and Wilkins</publisher-name>; <year>2000</year>.</mixed-citation></ref><ref id="pone.0180177.ref015"><label>15</label><mixed-citation publication-type="journal"><name><surname>MacKichan</surname><given-names>F</given-names></name>, <name><surname>Paterson</surname><given-names>C</given-names></name>, <name><surname>Henley</surname><given-names>WE</given-names></name>, <name><surname>Britten</surname><given-names>N</given-names></name>. <article-title>Self-care in people with long term health problems: a community based survey</article-title>. <source>BMC Family Practice</source>. <year>2011</year>;<volume>12</volume>:<fpage>53</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/1471-2296-12-53">10.1186/1471-2296-12-53</ext-link></comment>
<pub-id pub-id-type="pmid">21689455</pub-id></mixed-citation></ref><ref id="pone.0180177.ref016"><label>16</label><mixed-citation publication-type="journal"><name><surname>Ryan</surname><given-names>A</given-names></name>, <name><surname>Wilson</surname><given-names>S</given-names></name>, <name><surname>Taylor</surname><given-names>A</given-names></name>, <name><surname>Greenfield</surname><given-names>S</given-names></name>. <article-title>Factors associated with self-care activities among adults in the United Kingdom: a systematic review</article-title>. <source>BMC Public Health</source>. <year>2009</year>;<volume>9</volume>:<fpage>96</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/1471-2458-9-96">10.1186/1471-2458-9-96</ext-link></comment>
<pub-id pub-id-type="pmid">19344526</pub-id></mixed-citation></ref><ref id="pone.0180177.ref017"><label>17</label><mixed-citation publication-type="journal"><name><surname>Fisher</surname><given-names>C</given-names></name>, <name><surname>Adams</surname><given-names>J</given-names></name>, <name><surname>Hickman</surname><given-names>L</given-names></name>, <name><surname>Sibbritt</surname><given-names>D</given-names></name>. <article-title>The use of complementary and alternative medicine by 7427 Australian women with cyclic perimenstrual pain and discomfort: a cross-sectional study</article-title>. <source>BMC Complement Altern Med</source>. <year>2016</year>;<volume>16</volume>:<fpage>129</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/s12906-016-1119-8">10.1186/s12906-016-1119-8</ext-link></comment>
<pub-id pub-id-type="pmid">27189381</pub-id></mixed-citation></ref><ref id="pone.0180177.ref018"><label>18</label><mixed-citation publication-type="journal"><name><surname>Chang</surname><given-names>S-F</given-names></name>, <name><surname>Chuang</surname><given-names>M-H</given-names></name>. <article-title>Factors that affect self-care behaviour of female high school students with dysmenorrhoea: a cluster sampling study</article-title>. <source>International Journal of Nursing Practice</source>. <year>2012</year>;<volume>18</volume>(<issue>2</issue>):<fpage>117</fpage>&#x02013;<lpage>24</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/j.1440-172X.2012.02007.x">10.1111/j.1440-172X.2012.02007.x</ext-link></comment>
<pub-id pub-id-type="pmid">22435974</pub-id></mixed-citation></ref><ref id="pone.0180177.ref019"><label>19</label><mixed-citation publication-type="journal"><name><surname>Chia</surname><given-names>CF</given-names></name>, <name><surname>Lai</surname><given-names>JHY</given-names></name>, <name><surname>Cheung</surname><given-names>PK</given-names></name>, <name><surname>Kwong</surname><given-names>LT</given-names></name>, <name><surname>Lau</surname><given-names>FPM</given-names></name>, <name><surname>Leung</surname><given-names>KH</given-names></name>
<etal>et al</etal>
<article-title>Dysmenorrhoea among hong kong university students: prevalence, impact, and management</article-title>. <source>Hong Kong Medical Journal</source>. <year>2013</year>;<volume>19</volume>(<issue>3</issue>):<fpage>222</fpage>&#x02013;<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.12809/hkmj133807">10.12809/hkmj133807</ext-link></comment>
<pub-id pub-id-type="pmid">23568937</pub-id></mixed-citation></ref><ref id="pone.0180177.ref020"><label>20</label><mixed-citation publication-type="journal"><name><surname>Chen</surname><given-names>C-H</given-names></name>, <name><surname>Lin</surname><given-names>Y-H</given-names></name>, <name><surname>Heitkemper</surname><given-names>MM</given-names></name>, <name><surname>Wu</surname><given-names>K-M</given-names></name>. <article-title>The self-care strategies of girls with primary dysmenorrhea: a focus group study in taiwan</article-title>. <source>Health Care Women Int</source>. <year>2006</year>;<volume>27</volume>(<issue>5</issue>):<fpage>418</fpage>&#x02013;<lpage>27</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1080/07399330600629583">10.1080/07399330600629583</ext-link></comment>
<pub-id pub-id-type="pmid">16877292</pub-id></mixed-citation></ref><ref id="pone.0180177.ref021"><label>21</label><mixed-citation publication-type="journal"><name><surname>Smith</surname><given-names>CA</given-names></name>, <name><surname>Armour</surname><given-names>M</given-names></name>, <name><surname>Betts</surname><given-names>D</given-names></name>. <article-title>Treatment of women's reproductive health conditions by australian and new zealand acupuncturists</article-title>. <source>Complement Ther Med</source>. <year>2014</year>;<volume>22</volume>(<issue>4</issue>):<fpage>710</fpage>&#x02013;<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ctim.2014.06.001">10.1016/j.ctim.2014.06.001</ext-link></comment>
<pub-id pub-id-type="pmid">25146076</pub-id></mixed-citation></ref><ref id="pone.0180177.ref022"><label>22</label><mixed-citation publication-type="journal"><name><surname>Smith</surname><given-names>CA</given-names></name>, <name><surname>Armour</surname><given-names>M</given-names></name>, <name><surname>Zhu</surname><given-names>X</given-names></name>, <name><surname>Li</surname><given-names>X</given-names></name>, <name><surname>Lu</surname><given-names>ZY</given-names></name>, <name><surname>Song</surname><given-names>J</given-names></name>. <article-title>Acupuncture for dysmenorrhoea</article-title>. <source>Cochrane Database Syst Rev</source>. <year>2016</year>;<volume>4</volume>:<fpage>CD007854</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/14651858.CD007854.pub3">10.1002/14651858.CD007854.pub3</ext-link></comment>
<pub-id pub-id-type="pmid">27087494</pub-id></mixed-citation></ref><ref id="pone.0180177.ref023"><label>23</label><mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>S-M</given-names></name>, <name><surname>Kain</surname><given-names>ZN</given-names></name>, <name><surname>White</surname><given-names>P</given-names></name>. <article-title>Acupuncture analgesia: I. The scientific basis</article-title>. <source>Anesthesia and analgesia</source>. <year>2008</year>;<volume>106</volume>(<issue>2</issue>):<fpage>602</fpage>&#x02013;<lpage>10</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1213/01.ane.0000277493.42335.7b">10.1213/01.ane.0000277493.42335.7b</ext-link></comment>
<pub-id pub-id-type="pmid">18227322</pub-id></mixed-citation></ref><ref id="pone.0180177.ref024"><label>24</label><mixed-citation publication-type="journal"><name><surname>McDonald</surname><given-names>JL</given-names></name>, <name><surname>Cripps</surname><given-names>AW</given-names></name>, <name><surname>Smith</surname><given-names>PK</given-names></name>. <article-title>Mediators, Receptors, and Signalling Pathways in the Anti-Inflammatory and Antihyperalgesic Effects of Acupuncture</article-title>. <source>Evid Based Complement Alternat Med</source>. <year>2015</year>;<volume>2015</volume>:<fpage>975632</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1155/2015/975632">10.1155/2015/975632</ext-link></comment>
<pub-id pub-id-type="pmid">26339274</pub-id></mixed-citation></ref><ref id="pone.0180177.ref025"><label>25</label><mixed-citation publication-type="journal"><name><surname>Stener-Victorin</surname><given-names>E</given-names></name>, <name><surname>Waldenstr&#x000f6;m</surname><given-names>U</given-names></name>, <name><surname>Andersson</surname><given-names>SA</given-names></name>, <name><surname>Wikland</surname><given-names>M</given-names></name>. <article-title>Reduction of blood flow impedance in the uterine arteries of infertile women with electro-acupuncture</article-title>. <source>Hum Reprod</source>. <year>1996</year>;<volume>11</volume>(<issue>6</issue>):<fpage>1314</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="pmid">8671446</pub-id></mixed-citation></ref><ref id="pone.0180177.ref026"><label>26</label><mixed-citation publication-type="journal"><name><surname>Xu</surname><given-names>T</given-names></name>, <name><surname>Hui</surname><given-names>L</given-names></name>, <name><surname>Juan</surname><given-names>YL</given-names></name>, <name><surname>Min</surname><given-names>SG</given-names></name>, <name><surname>Hua</surname><given-names>WT</given-names></name>. <article-title>Effects of moxibustion or acupoint therapy for the treatment of primary dysmenorrhea: a meta-analysis</article-title>. <source>Altern Ther Health Med</source>. <year>2014</year>;<volume>20</volume>(<issue>4</issue>):<fpage>33</fpage>&#x02013;<lpage>42</lpage>. <pub-id pub-id-type="pmid">25141361</pub-id></mixed-citation></ref><ref id="pone.0180177.ref027"><label>27</label><mixed-citation publication-type="journal"><name><surname>Harris</surname><given-names>RE</given-names></name>, <name><surname>Tian</surname><given-names>X</given-names></name>, <name><surname>Williams</surname><given-names>DA</given-names></name>, <name><surname>Tian</surname><given-names>TX</given-names></name>, <name><surname>Cupps</surname><given-names>TR</given-names></name>, <name><surname>Petzke</surname><given-names>F</given-names></name>
<etal>et al</etal>
<article-title>Treatment of fibromyalgia with formula acupuncture: investigation of needle placement, needle stimulation, and treatment frequency</article-title>. <source>Journal of Alternative &#x00026; Complementary Medicine</source>. <year>2005</year>;<volume>11</volume>(<issue>4</issue>):<fpage>663</fpage>&#x02013;<lpage>71</lpage>.<pub-id pub-id-type="pmid">16131290</pub-id></mixed-citation></ref><ref id="pone.0180177.ref028"><label>28</label><mixed-citation publication-type="journal"><name><surname>Zhi</surname><given-names>L</given-names></name>. <article-title>Randomised controlled study on superficial needling for treatment of primary dysmenorrhea</article-title>. <source>Chinese Acupuncture and Moxibustion</source>. <year>2007</year>;<volume>27</volume>(<issue>1</issue>):<fpage>18</fpage>&#x02013;<lpage>21</lpage>. <pub-id pub-id-type="pmid">17378197</pub-id></mixed-citation></ref><ref id="pone.0180177.ref029"><label>29</label><mixed-citation publication-type="journal"><name><surname>Ma</surname><given-names>Y-X</given-names></name>, <name><surname>Ye</surname><given-names>X-N</given-names></name>, <name><surname>Liu</surname><given-names>C-Z</given-names></name>, <name><surname>Cai</surname><given-names>P-Y</given-names></name>, <name><surname>Li</surname><given-names>Z-F</given-names></name>, <name><surname>Du</surname><given-names>D-Q</given-names></name>
<etal>et al</etal>
<article-title>A clinical trial of acupuncture about time-varying treatment and points selection in primary dysmenorrhea</article-title>. <source>J Ethnopharmacol</source>. <year>2013</year>;<volume>148</volume>(<issue>2</issue>):<fpage>498</fpage>&#x02013;<lpage>504</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jep.2013.04.045">10.1016/j.jep.2013.04.045</ext-link></comment>
<pub-id pub-id-type="pmid">23684618</pub-id></mixed-citation></ref><ref id="pone.0180177.ref030"><label>30</label><mixed-citation publication-type="journal"><name><surname>Bu</surname><given-names>Y-Q</given-names></name>, <name><surname>Du</surname><given-names>G-Z</given-names></name>, <name><surname>Chen</surname><given-names>S-Z</given-names></name>. <article-title>Clinical study on the treatment of primary dysmenorrhea with preconditioning acupuncture</article-title>. <source>Chin J Integr Med</source>. <year>2011</year>;<volume>17</volume>(<issue>3</issue>):<fpage>224</fpage>&#x02013;<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s11655-011-0671-9">10.1007/s11655-011-0671-9</ext-link></comment>
<pub-id pub-id-type="pmid">21359925</pub-id></mixed-citation></ref><ref id="pone.0180177.ref031"><label>31</label><mixed-citation publication-type="journal"><name><surname>Schnyer</surname><given-names>RN</given-names></name>, <name><surname>Allen</surname><given-names>JJB</given-names></name>. <article-title>Bridging the gap in complementary and alternative medicine research: manualization as a means of promoting standardization and flexibility of treatment in clinical trials of acupuncture</article-title>. <source>J Altern Complement Med</source>. <year>2002</year>;<volume>8</volume>(<issue>5</issue>):<fpage>623</fpage>&#x02013;<lpage>34</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1089/107555302320825147">10.1089/107555302320825147</ext-link></comment>
<pub-id pub-id-type="pmid">12470444</pub-id></mixed-citation></ref><ref id="pone.0180177.ref032"><label>32</label><mixed-citation publication-type="journal"><name><surname>Macpherson</surname><given-names>H</given-names></name>. <article-title>Pragmatic clinical trials</article-title>. <source>Complement Ther Med</source>. <year>2004</year>;<volume>12</volume>(<issue>2&#x02013;3</issue>):<fpage>136</fpage>&#x02013;<lpage>40</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ctim.2004.07.043">10.1016/j.ctim.2004.07.043</ext-link></comment>
<pub-id pub-id-type="pmid">15561524</pub-id></mixed-citation></ref><ref id="pone.0180177.ref033"><label>33</label><mixed-citation publication-type="journal"><name><surname>MacPherson</surname><given-names>H</given-names></name>, <name><surname>Altman</surname><given-names>DG</given-names></name>, <name><surname>Hammerschlag</surname><given-names>R</given-names></name>, <name><surname>Li</surname><given-names>Y</given-names></name>, <name><surname>Wu</surname><given-names>T</given-names></name>, <name><surname>White</surname><given-names>A</given-names></name>
<etal>et al</etal>
<article-title>Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): extending the CONSORT statement</article-title>. <source>Acupunct Med</source>. <year>2010</year>;<volume>28</volume>(<issue>2</issue>):<fpage>83</fpage>&#x02013;<lpage>93</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1136/aim.2009.001370">10.1136/aim.2009.001370</ext-link></comment>
<pub-id pub-id-type="pmid">20615861</pub-id></mixed-citation></ref><ref id="pone.0180177.ref034"><label>34</label><mixed-citation publication-type="journal"><name><surname>O'Connell</surname><given-names>K</given-names></name>, <name><surname>Davis</surname><given-names>AR</given-names></name>, <name><surname>Westhoff</surname><given-names>C</given-names></name>. <article-title>Self-treatment patterns among adolescent girls with dysmenorrhea</article-title>. <source>J Pediatr Adolesc Gynecol</source>. <year>2006</year>;<volume>19</volume>(<issue>4</issue>):<fpage>285</fpage>&#x02013;<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jpag.2006.05.004">10.1016/j.jpag.2006.05.004</ext-link></comment>
<pub-id pub-id-type="pmid">16873033</pub-id></mixed-citation></ref><ref id="pone.0180177.ref035"><label>35</label><mixed-citation publication-type="journal"><name><surname>Griffin</surname><given-names>HJ</given-names></name>, <name><surname>O'Connor</surname><given-names>HT</given-names></name>, <name><surname>Rooney</surname><given-names>KB</given-names></name>, <name><surname>Steinbeck</surname><given-names>KS</given-names></name>. <article-title>Effectiveness of strategies for recruiting overweight and obese Generation Y women to a clinical weight management trial</article-title>. <source>Asia Pacific journal of clinical nutrition</source>. <year>2013</year>;<volume>22</volume>(<issue>2</issue>):<fpage>235</fpage>&#x02013;<lpage>40</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.6133/apjcn.2013.22.2.16">10.6133/apjcn.2013.22.2.16</ext-link></comment>
<pub-id pub-id-type="pmid">23635367</pub-id></mixed-citation></ref><ref id="pone.0180177.ref036"><label>36</label><mixed-citation publication-type="journal"><name><surname>Liu</surname><given-names>Y-Q</given-names></name>, <name><surname>Ma</surname><given-names>L-X</given-names></name>, <name><surname>Xing</surname><given-names>J-M</given-names></name>, <name><surname>Cao</surname><given-names>H-J</given-names></name>, <name><surname>Wang</surname><given-names>Y-X</given-names></name>, <name><surname>Tang</surname><given-names>L</given-names></name>
<etal>et al</etal>
<article-title>Does traditional chinese medicine pattern affect acupoint specific effect? analysis of data from a multicenter, randomized, controlled trial for primary dysmenorrhea</article-title>. <source>J Altern Complement Med</source>. <year>2012</year>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1089/acm.2011.0404">10.1089/acm.2011.0404</ext-link></comment>
<pub-id pub-id-type="pmid">22823583</pub-id></mixed-citation></ref><ref id="pone.0180177.ref037"><label>37</label><mixed-citation publication-type="book"><name><surname>Deadman</surname><given-names>P</given-names></name>, <name><surname>Al-Khafaji</surname><given-names>M</given-names></name>, <name><surname>Baker</surname><given-names>K</given-names></name>. <source>A manual of acupuncture</source>. <edition>2nd, revised ed.</edition>
<publisher-loc>Hove, East Sussex, England</publisher-loc>: <publisher-name>Journal of Chinese Medicine</publisher-name>; <year>1998</year>.</mixed-citation></ref><ref id="pone.0180177.ref038"><label>38</label><mixed-citation publication-type="journal"><name><surname>White</surname><given-names>A</given-names></name>, <name><surname>Cummings</surname><given-names>M</given-names></name>, <name><surname>Barlas</surname><given-names>P</given-names></name>, <name><surname>Cardini</surname><given-names>F</given-names></name>, <name><surname>Filshie</surname><given-names>J</given-names></name>, <name><surname>Foster</surname><given-names>NE</given-names></name>
<etal>et al</etal>
<article-title>Defining an adequate dose of acupuncture using a neurophysiological approach&#x02014;a narrative review of the literature</article-title>. <source>Acupunct Med</source>. <year>2008</year>;<volume>26</volume>(<issue>2</issue>):<fpage>111</fpage>&#x02013;<lpage>20</lpage>. <pub-id pub-id-type="pmid">18591910</pub-id></mixed-citation></ref><ref id="pone.0180177.ref039"><label>39</label><mixed-citation publication-type="journal"><name><surname>Hjermstad</surname><given-names>MJ</given-names></name>, <name><surname>Fayers</surname><given-names>PM</given-names></name>, <name><surname>Haugen</surname><given-names>DF</given-names></name>, <name><surname>Caraceni</surname><given-names>A</given-names></name>, <name><surname>Hanks</surname><given-names>GW</given-names></name>, <name><surname>Loge</surname><given-names>JH</given-names></name>
<etal>et al</etal>
<article-title>Studies comparing Numerical Rating Scales, Verbal Rating Scales, and Visual Analogue Scales for assessment of pain intensity in adults: a systematic literature review</article-title>. <source>J Pain Symptom Manage</source>. <year>2011</year>;<volume>41</volume>(<issue>6</issue>):<fpage>1073</fpage>&#x02013;<lpage>93</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jpainsymman.2010.08.016">10.1016/j.jpainsymman.2010.08.016</ext-link></comment>
<pub-id pub-id-type="pmid">21621130</pub-id></mixed-citation></ref><ref id="pone.0180177.ref040"><label>40</label><mixed-citation publication-type="journal"><name><surname>Brazier</surname><given-names>JE</given-names></name>, <name><surname>Harper</surname><given-names>R</given-names></name>, <name><surname>Jones</surname><given-names>NM</given-names></name>, <name><surname>O'Cathain</surname><given-names>A</given-names></name>, <name><surname>Thomas</surname><given-names>KJ</given-names></name>, <name><surname>Usherwood</surname><given-names>T</given-names></name>
<etal>et al</etal>
<article-title>Validating the SF-36 health survey questionnaire: new outcome measure for primary care</article-title>. <source>BMJ</source>. <year>1992</year>;<volume>305</volume>(<issue>6846</issue>):<fpage>160</fpage>&#x02013;<lpage>4</lpage>. <pub-id pub-id-type="pmid">1285753</pub-id></mixed-citation></ref><ref id="pone.0180177.ref041"><label>41</label><mixed-citation publication-type="journal"><name><surname>Unsal</surname><given-names>A</given-names></name>, <name><surname>Ayranci</surname><given-names>U</given-names></name>, <name><surname>Tozun</surname><given-names>M</given-names></name>, <name><surname>Arslan</surname><given-names>G</given-names></name>, <name><surname>Calik</surname><given-names>E</given-names></name>. <article-title>Prevalence of dysmenorrhea and its effect on quality of life among a group of female university students</article-title>. <source>Ups J Med Sci</source>. <year>2010</year>;<volume>115</volume>(<issue>2</issue>):<fpage>138</fpage>&#x02013;<lpage>45</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3109/03009730903457218">10.3109/03009730903457218</ext-link></comment>
<pub-id pub-id-type="pmid">20074018</pub-id></mixed-citation></ref><ref id="pone.0180177.ref042"><label>42</label><mixed-citation publication-type="journal"><name><surname>Dworkin</surname><given-names>RH</given-names></name>, <name><surname>Turk</surname><given-names>DC</given-names></name>, <name><surname>Wyrwich</surname><given-names>KW</given-names></name>, <name><surname>Beaton</surname><given-names>D</given-names></name>, <name><surname>Cleeland</surname><given-names>CS</given-names></name>, <name><surname>Farrar</surname><given-names>JT</given-names></name>
<etal>et al</etal>
<article-title>Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations</article-title>. <source>J Pain</source>. <year>2008</year>;<volume>9</volume>(<issue>2</issue>):<fpage>105</fpage>&#x02013;<lpage>21</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jpain.2007.09.005">10.1016/j.jpain.2007.09.005</ext-link></comment>
<pub-id pub-id-type="pmid">18055266</pub-id></mixed-citation></ref><ref id="pone.0180177.ref043"><label>43</label><mixed-citation publication-type="journal"><name><surname>Dworkin</surname><given-names>RH</given-names></name>, <name><surname>Turk</surname><given-names>DC</given-names></name>, <name><surname>McDermott</surname><given-names>MP</given-names></name>, <name><surname>Peirce-Sandner</surname><given-names>S</given-names></name>, <name><surname>Burke</surname><given-names>LB</given-names></name>, <name><surname>Cowan</surname><given-names>P</given-names></name>
<etal>et al</etal>
<article-title>Interpreting the clinical importance of group differences in chronic pain clinical trials: IMMPACT recommendations</article-title>. <source>Pain</source>. <year>2009</year>;<volume>146</volume>(<issue>3</issue>):<fpage>238</fpage>&#x02013;<lpage>44</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.pain.2009.08.019">10.1016/j.pain.2009.08.019</ext-link></comment>
<pub-id pub-id-type="pmid">19836888</pub-id></mixed-citation></ref><ref id="pone.0180177.ref044"><label>44</label><mixed-citation publication-type="journal"><name><surname>Smith</surname><given-names>CA</given-names></name>, <name><surname>Crowther</surname><given-names>CA</given-names></name>, <name><surname>Petrucco</surname><given-names>O</given-names></name>, <name><surname>Beilby</surname><given-names>J</given-names></name>, <name><surname>Dent</surname><given-names>H</given-names></name>. <article-title>Acupuncture to treat primary dysmenorrhea in women: a randomized controlled trial</article-title>. <source>Evid Based Complement Alternat Med</source>. <year>2011</year>;<volume>2011</volume>:<fpage>612464</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/ecam/nep239">10.1093/ecam/nep239</ext-link></comment>
<pub-id pub-id-type="pmid">21799683</pub-id></mixed-citation></ref><ref id="pone.0180177.ref045"><label>45</label><mixed-citation publication-type="journal"><name><surname>Witt</surname><given-names>CM</given-names></name>, <name><surname>Reinhold</surname><given-names>T</given-names></name>, <name><surname>Brinkhaus</surname><given-names>B</given-names></name>, <name><surname>Roll</surname><given-names>S</given-names></name>, <name><surname>Jena</surname><given-names>S</given-names></name>, <name><surname>Willich</surname><given-names>SN</given-names></name>. <article-title>Acupuncture in patients with dysmenorrhea: a randomized study on clinical effectiveness and cost-effectiveness in usual care</article-title>. <source>Am J Obstet Gynecol</source>. <year>2008</year>;<volume>198</volume>(<issue>2</issue>):<fpage>166.e1</fpage>&#x02013;<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ajog.2007.07.041">10.1016/j.ajog.2007.07.041</ext-link></comment>
<pub-id pub-id-type="pmid">18226614</pub-id></mixed-citation></ref><ref id="pone.0180177.ref046"><label>46</label><mixed-citation publication-type="journal"><name><surname>Guo</surname><given-names>HF</given-names></name>, <name><surname>Tian</surname><given-names>J</given-names></name>, <name><surname>Wang</surname><given-names>X</given-names></name>, <name><surname>Fang</surname><given-names>Y</given-names></name>, <name><surname>Hou</surname><given-names>Y</given-names></name>, <name><surname>Han</surname><given-names>J</given-names></name>. <article-title>Brain substrates activated by electroacupuncture of different frequencies (I): Comparative study on the expression of oncogene c-fos and genes coding for three opioid peptides</article-title>. <source>Brain Res Mol Brain Res</source>. <year>1996</year>;<volume>43</volume>(<issue>1&#x02013;2</issue>):<fpage>157</fpage>&#x02013;<lpage>66</lpage>. <pub-id pub-id-type="pmid">9037529</pub-id></mixed-citation></ref><ref id="pone.0180177.ref047"><label>47</label><mixed-citation publication-type="journal"><name><surname>Mayor</surname><given-names>D</given-names></name>. <article-title>An exploratory review of the electroacupuncture literature: clinical applications and endorphin mechanisms</article-title>. <source>Acupunct Med</source>. <year>2013</year>;<volume>31</volume>(<issue>4</issue>):<fpage>409</fpage>&#x02013;<lpage>15</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1136/acupmed-2013-010324">10.1136/acupmed-2013-010324</ext-link></comment>
<pub-id pub-id-type="pmid">23917395</pub-id></mixed-citation></ref><ref id="pone.0180177.ref048"><label>48</label><mixed-citation publication-type="journal"><name><surname>Liu</surname><given-names>C-Z</given-names></name>, <name><surname>Xie</surname><given-names>J-P</given-names></name>, <name><surname>Wang</surname><given-names>L-P</given-names></name>, <name><surname>Zheng</surname><given-names>Y-Y</given-names></name>, <name><surname>Ma</surname><given-names>Z-B</given-names></name>, <name><surname>Yang</surname><given-names>H</given-names></name>
<etal>et al</etal>
<article-title>Immediate analgesia effect of single point acupuncture in primary dysmenorrhea: a randomized controlled trial</article-title>. <source>Pain Med</source>. <year>2011</year>;<volume>12</volume>(<issue>2</issue>):<fpage>300</fpage>&#x02013;<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/j.1526-4637.2010.01017.x">10.1111/j.1526-4637.2010.01017.x</ext-link></comment>
<pub-id pub-id-type="pmid">21166767</pub-id></mixed-citation></ref><ref id="pone.0180177.ref049"><label>49</label><mixed-citation publication-type="journal"><name><surname>Shi</surname><given-names>G-X</given-names></name>, <name><surname>Liu</surname><given-names>C-Z</given-names></name>, <name><surname>Zhu</surname><given-names>J</given-names></name>, <name><surname>Guan</surname><given-names>L-P</given-names></name>, <name><surname>Wang</surname><given-names>D-J</given-names></name>, <name><surname>Wu</surname><given-names>M-M</given-names></name>. <article-title>Effects of acupuncture at sanyinjiao (SP6) on prostaglandin levels in primary dysmenorrhea patients</article-title>. <source>The Clinical journal of pain</source>. <year>2011</year>;<volume>27</volume>(<issue>3</issue>):<fpage>258</fpage>&#x02013;<lpage>61</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1097/AJP.0b013e3181fb27ae">10.1097/AJP.0b013e3181fb27ae</ext-link></comment>
<pub-id pub-id-type="pmid">21358291</pub-id></mixed-citation></ref><ref id="pone.0180177.ref050"><label>50</label><mixed-citation publication-type="journal"><name><surname>Ma</surname><given-names>Y-X</given-names></name>, <name><surname>Ma</surname><given-names>L-X</given-names></name>, <name><surname>Liu</surname><given-names>X-L</given-names></name>, <name><surname>Ma</surname><given-names>Y-X</given-names></name>, <name><surname>Lv</surname><given-names>K</given-names></name>, <name><surname>Wang</surname><given-names>D</given-names></name>
<etal>et al</etal>
<article-title>A comparative study on the immediate effects of electroacupuncture at sanyinjiao (SP6), xuanzhong (GB39) and a non-meridian point, on menstrual pain and uterine arterial blood flow, in primary dysmenorrhea patients</article-title>. <source>Pain Med</source>. <year>2010</year>;<volume>11</volume>(<issue>10</issue>):<fpage>1564</fpage>&#x02013;<lpage>75</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/j.1526-4637.2010.00949.x">10.1111/j.1526-4637.2010.00949.x</ext-link></comment>
<pub-id pub-id-type="pmid">21199306</pub-id></mixed-citation></ref><ref id="pone.0180177.ref051"><label>51</label><mixed-citation publication-type="journal"><name><surname>Liu</surname><given-names>C-Z</given-names></name>, <name><surname>Xie</surname><given-names>J-P</given-names></name>, <name><surname>Wang</surname><given-names>L-P</given-names></name>, <name><surname>Liu</surname><given-names>Y-Q</given-names></name>, <name><surname>Song</surname><given-names>J-S</given-names></name>, <name><surname>Chen</surname><given-names>Y-Y</given-names></name>
<etal>et al</etal>
<article-title>A randomized controlled trial of single point acupuncture in primary dysmenorrhea</article-title>. <source>Pain Med</source>. <year>2014</year>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/pme.12392">10.1111/pme.12392</ext-link></comment>
<pub-id pub-id-type="pmid">24636695</pub-id></mixed-citation></ref><ref id="pone.0180177.ref052"><label>52</label><mixed-citation publication-type="journal"><name><surname>Liu</surname><given-names>F</given-names></name>, <name><surname>Xiong</surname><given-names>J</given-names></name>, <name><surname>Huang</surname><given-names>G-y</given-names></name>, <name><surname>Wang</surname><given-names>W</given-names></name>. [<article-title>Study on the underlying mechanism of acupuncture in regulating neuroendocrine activity in dysmenorrhea rats</article-title>]. <source>Zhen Ci Yan Jiu</source>. <year>2009</year>;<volume>34</volume>(<issue>1</issue>):<fpage>3</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="pmid">19526799</pub-id></mixed-citation></ref><ref id="pone.0180177.ref053"><label>53</label><mixed-citation publication-type="journal"><name><surname>Stener-Victorin</surname><given-names>E</given-names></name>, <name><surname>Fujisawa</surname><given-names>S</given-names></name>, <name><surname>Kurosawa</surname><given-names>M</given-names></name>. <article-title>Ovarian blood flow responses to electroacupuncture stimulation depend on estrous cycle and on site and frequency of stimulation in anesthetized rats</article-title>. <source>Journal of Applied Physiology</source>. <year>2006</year>;<volume>101</volume>(<issue>1</issue>):<fpage>84</fpage>&#x02013;<lpage>91</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1152/japplphysiol.01593.2005">10.1152/japplphysiol.01593.2005</ext-link></comment>
<pub-id pub-id-type="pmid">16514000</pub-id></mixed-citation></ref><ref id="pone.0180177.ref054"><label>54</label><mixed-citation publication-type="journal"><name><surname>Meiqing</surname><given-names>W</given-names></name>, <name><surname>Jiang</surname><given-names>Z</given-names></name>, <name><surname>Lufen</surname><given-names>Z</given-names></name>. <article-title>Experimental study on the mechanism of electroacupuncture at LI 4 and SP 6 points for promoting labor</article-title>. <source>Chinese Acupuncture &#x00026; Moxibustion</source>. <year>2003</year>;<volume>10</volume>:<fpage>012</fpage>.</mixed-citation></ref><ref id="pone.0180177.ref055"><label>55</label><mixed-citation publication-type="journal"><name><surname>Celik</surname><given-names>H</given-names></name>, <name><surname>Gurates</surname><given-names>B</given-names></name>, <name><surname>Parmaksiz</surname><given-names>C</given-names></name>, <name><surname>Polat</surname><given-names>A</given-names></name>, <name><surname>Hanay</surname><given-names>F</given-names></name>, <name><surname>Kavak</surname><given-names>B</given-names></name>
<etal>et al</etal>
<article-title>Severity of pain and circadian changes in uterine artery blood flow in primary dysmenorrhea</article-title>. <source>Arch Gynecol Obstet</source>. <year>2009</year>;<volume>280</volume>(<issue>4</issue>):<fpage>589</fpage>&#x02013;<lpage>92</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s00404-009-0966-7">10.1007/s00404-009-0966-7</ext-link></comment>
<pub-id pub-id-type="pmid">19219445</pub-id></mixed-citation></ref><ref id="pone.0180177.ref056"><label>56</label><mixed-citation publication-type="journal"><name><surname>Dmitrovi&#x00107;</surname><given-names>R</given-names></name>. <article-title>Transvaginal color doppler study of uterine blood flow in primary dysmenorrhea</article-title>. <source>Acta Obstet Gynecol Scand</source>. <year>2000</year>;<volume>79</volume>(<issue>12</issue>):<fpage>1112</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="pmid">11130097</pub-id></mixed-citation></ref><ref id="pone.0180177.ref057"><label>57</label><mixed-citation publication-type="journal"><name><surname>Yu</surname><given-names>Y-P</given-names></name>, <name><surname>Ma</surname><given-names>L-X</given-names></name>, <name><surname>Ma</surname><given-names>Y-X</given-names></name>, <name><surname>Ma</surname><given-names>Y-X</given-names></name>, <name><surname>Liu</surname><given-names>Y-Q</given-names></name>, <name><surname>Liu</surname><given-names>C-Z</given-names></name>
<etal>et al</etal>
<article-title>Immediate effect of acupuncture at sanyinjiao (SP6) and xuanzhong (GB39) on uterine arterial blood flow in primary dysmenorrhea</article-title>. <source>J Altern Complement Med</source>. <year>2010</year>;<volume>16</volume>(<issue>10</issue>):<fpage>1073</fpage>&#x02013;<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1089/acm.2009.0326">10.1089/acm.2009.0326</ext-link></comment>
<pub-id pub-id-type="pmid">20932189</pub-id></mixed-citation></ref><ref id="pone.0180177.ref058"><label>58</label><mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>SM</given-names></name>, <name><surname>Kain</surname><given-names>ZN</given-names></name>, <name><surname>White</surname><given-names>P</given-names></name>. <article-title>Acupuncture analgesia: I. The scientific basis</article-title>. <source>Anesth Analg</source>. <year>2008</year>;<volume>106</volume>(<issue>2</issue>):<fpage>602</fpage>&#x02013;<lpage>10</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1213/01.ane.0000277493.42335.7b">10.1213/01.ane.0000277493.42335.7b</ext-link></comment>
<pub-id pub-id-type="pmid">18227322</pub-id></mixed-citation></ref><ref id="pone.0180177.ref059"><label>59</label><mixed-citation publication-type="journal"><name><surname>Dawood</surname><given-names>MY</given-names></name>. <article-title>Primary dysmenorrhea: advances in pathogenesis and management</article-title>. <source>Obstet Gynecol</source>. <year>2006</year>;<volume>108</volume>(<issue>2</issue>):<fpage>428</fpage>&#x02013;<lpage>41</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1097/01.AOG.0000230214.26638.0c">10.1097/01.AOG.0000230214.26638.0c</ext-link></comment>
<pub-id pub-id-type="pmid">16880317</pub-id></mixed-citation></ref><ref id="pone.0180177.ref060"><label>60</label><mixed-citation publication-type="journal"><name><surname>Gold</surname><given-names>EB</given-names></name>, <name><surname>Wells</surname><given-names>C</given-names></name>, <name><surname>Rasor</surname><given-names>MON</given-names></name>. <article-title>The Association of Inflammation with Premenstrual Symptoms</article-title>. <source>Journal of Women's Health</source>. <year>2016</year>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1089/jwh.2015.5529">10.1089/jwh.2015.5529</ext-link></comment>
<pub-id pub-id-type="pmid">27135720</pub-id></mixed-citation></ref><ref id="pone.0180177.ref061"><label>61</label><mixed-citation publication-type="journal"><name><surname>Langevin</surname><given-names>H</given-names></name>, <name><surname>Schnyer</surname><given-names>R</given-names></name>, <name><surname>MacPherson</surname><given-names>H</given-names></name>, <name><surname>Davis</surname><given-names>R</given-names></name>, <name><surname>Harris</surname><given-names>RE</given-names></name>, <name><surname>Napadow</surname><given-names>V</given-names></name>
<etal>et al</etal>
<article-title>Manual and Electrical Needle Stimulation in Acupuncture Research: Pitfalls and Challenges of Heterogeneity</article-title>. <source>J Altern Complement Med</source>. <year>2015</year>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1089/acm.2014.0186">10.1089/acm.2014.0186</ext-link></comment>
<pub-id pub-id-type="pmid">25710206</pub-id></mixed-citation></ref><ref id="pone.0180177.ref062"><label>62</label><mixed-citation publication-type="book"><name><surname>Ware</surname><given-names>JE</given-names></name>, <name><surname>Kosinski</surname><given-names>M</given-names></name>, <name><surname>Keller</surname><given-names>S</given-names></name>. <source>SF-36 physical and mental health summary scales: a user's manual</source>. <publisher-loc>Boston</publisher-loc>: <publisher-name>Health Institute, New England Medical Center</publisher-name>; <year>1994</year>.</mixed-citation></ref><ref id="pone.0180177.ref063"><label>63</label><mixed-citation publication-type="journal"><name><surname>Baker</surname><given-names>FC</given-names></name>, <name><surname>Driver</surname><given-names>HS</given-names></name>, <name><surname>Rogers</surname><given-names>GG</given-names></name>, <name><surname>Paiker</surname><given-names>J</given-names></name>, <name><surname>Mitchell</surname><given-names>D</given-names></name>. <article-title>High nocturnal body temperatures and disturbed sleep in women with primary dysmenorrhea</article-title>. <source>Am J Physiol</source>. <year>1999</year>;<volume>277</volume>(<issue>6</issue> Pt 1):<fpage>E1013</fpage>&#x02013;<lpage>21</lpage>.<pub-id pub-id-type="pmid">10600789</pub-id></mixed-citation></ref><ref id="pone.0180177.ref064"><label>64</label><mixed-citation publication-type="journal"><name><surname>Helms</surname><given-names>JM</given-names></name>. <article-title>Acupuncture for the management of primary dysmenorrhea</article-title>. <source>Obstet Gynecol</source>. <year>1987</year>;<volume>69</volume>(<issue>1</issue>):<fpage>51</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="pmid">3540764</pub-id></mixed-citation></ref><ref id="pone.0180177.ref065"><label>65</label><mixed-citation publication-type="journal"><name><surname>Zhu</surname><given-names>X</given-names></name>, <name><surname>Wong</surname><given-names>F</given-names></name>, <name><surname>Bensoussan</surname><given-names>A</given-names></name>, <name><surname>Lo</surname><given-names>SK</given-names></name>, <name><surname>Zhou</surname><given-names>C</given-names></name>, <name><surname>Yu</surname><given-names>J</given-names></name>. <article-title>Are there any cross-ethnic differences in menstrual profiles? a pilot comparative study on australian and chinese women with primary dysmenorrhea</article-title>. <source>The Journal of Obstetrics and Gynaecology Research</source>. <year>2010</year>;<volume>36</volume>(<issue>5</issue>):<fpage>1093</fpage>&#x02013;<lpage>101</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/j.1447-0756.2010.01250.x">10.1111/j.1447-0756.2010.01250.x</ext-link></comment>
<pub-id pub-id-type="pmid">20846252</pub-id></mixed-citation></ref><ref id="pone.0180177.ref066"><label>66</label><mixed-citation publication-type="journal"><name><surname>Weissman</surname><given-names>AM</given-names></name>, <name><surname>Hartz</surname><given-names>AJ</given-names></name>, <name><surname>Hansen</surname><given-names>MD</given-names></name>, <name><surname>Johnson</surname><given-names>SR</given-names></name>. <article-title>The natural history of primary dysmenorrhoea: a longitudinal study</article-title>. <source>BJOG</source>. <year>2004</year>;<volume>111</volume>(<issue>4</issue>):<fpage>345</fpage>&#x02013;<lpage>52</lpage>. <pub-id pub-id-type="pmid">15008771</pub-id></mixed-citation></ref></ref-list></back></article>